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Abstract 
This thesis deals with the optimization of high-throughput cell-free protein expression 
and subsequent protein analysis as well as the combination of these methods. The 
research outcome contributes to help simplifying and accelerating the biochemical 
protein production and analysis. The conventional cell-based expression methods are 
limited in expressing gene sequences, which could not yet been assigned by defined 
functions. Using cell-free expression, proteins with special properties, which are of 
high value in the personalized medicine and pharmaceutical research, can be 
produced from these gene sequences. In this research, not only the optimization of 
cell-free expression systems and their use in various protein expressions, but also the 
subsequent analysis of the proteins were examined. Each of the two steps, protein 
production and protein analysis, were further developed from laboratory scale to high-
throughput methods to enlarge the number of experiments in a shorter timeframe with 
less material costs. To demonstrate the applicability of the new method, the results 
were compared to cell-based expression experiments.  
In recent years, in biotechnology and particularly the field of proteomics, the demand 
for faster and easier methods for protein production has grown. This methodology 
expansion is focused on making genetic information more efficiently useable. Here, 
cell-free expression plays a key role as it provides a powerful technological platform to 
prepare proteins from DNA templates [1–3]. Cell-free expression consists of two 
steps, the production of the cell extract and the cell-free protein-producing reaction. At 
the beginning of this study cell lysates from three different genetically modified 
bacterial cells of the strain Escherichia coli and two eukaryotic insect cell types (Sf9 
and High Five™) were prepared. The cell disruption method and further processing of 
the cell lysate contribute to increased protein yield; therefore three different methods 
(pressure digestion by French press or cell homogenization or freezing / thawing) 
were performed and optimized. Furthermore, the lysates differ in protein expression 
characteristics, depending on the cell type and strain. For example, the RNaseE 
mutant of the E. coli strain BL21 Star™ (DE3) proved to be very efficient in cell-free 
protein expression. The gene sequence of the RNaseE enzyme, which is usually 
responsible for the destruction of foreign mRNA, was removed and therefore the 
production of this enzyme is suppressed. Cell-free protein expression using this lysate 
is advantageous as the newly formed mRNA is not destroyed by the cell lysate 
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enzymes. By expression screenings in various cell-free expression systems, the cell-
free expression, depending on the desired application of the protein, and the protein 
type has been selected to produce proteins either in a high yield or with the desired 
post-translational modifications. 
The basis of all protein expressions is the gencoding DNA sequence that is translated 
during the reaction into the respective protein. In this study, only plasmids were used 
as DNA carriers. All plasmids contained the T7 promoter system, which produces high 
RNA levels using the T7 RNA polymerase and thus laying the basis for a high amount 
of protein. The cDNA sequences were cloned into the pET24d vector for the E. coli 
expression and into the plasmid pDT1 [4] for insect cell-free reaction. This 
differentiation between the cell types and the usage of these two vectors has proven 
to be appropriate to enhance the protein yield, which was shown in studies carried out 
at the beginning of this thesis. The DNA sequences of the respective proteins usually 
contain an N- or C-terminal His-tag for the protein specific detection or purification. 
The DNA for a special protein attachment, the HaloTag
®
 [5] was additionally cloned 
behind or in front of the coding sequence for the protein to specifically immobilize 
them on treated surfaces after expression.  
The cell-free protein producing reaction (herein referred to as cell-free expression) 
consists universally of the same two parts, the transcription and translation. The 
difference of prokaryotes and eukaryotes is the location of the expression processes. 
Whereas in prokaryotes the transcription and translation run simultaneously within the 
cell, in eukaryotes transcription takes place in the cell nucleus and the translation is 
then performed in the intracellular fluid. During transcription, an mRNA template is 
created from a DNA template, which in turn is translated into a peptide chain. 
Depending on the protein and cell type, the peptide chain is modified either through 
post-translational modifications or a folding of the proteins including helper proteins. 
These final protein modifications may constitute the decisive factor for a successful 
deployment of the proteins, depending on the desired application of the produced 
proteins. For example, the addition of various folding proteins has been successfully 
tested and used in the cell-free expression with E. coli. In this study, all E. coli made 
cell-free expressions were performed as ‘coupled-reactions’, meaning that the 
transcription and translation are executed simultaneously in one reaction vessel. In 
contrast to that, the in vitro insect cell expressions were performed connected in 
‘linked-reactions’. This means that the mRNA is transferred to a second reaction 
vessel after the transcription, to perform the translation separately.  
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Prior to the application of the cell-free expression systems for the production of 
various proteins was the particular characterization and optimization of the reaction 
compositions. A cell-free expression consists of the cell lysate, including the tRNAs, 
various enzymes and the ribosomes. For a successful protein expression T7 RNA 
polymerase, 20 proteinogenic amino acids, energy in form of GTP and ATP as well as 
an energy regenerating system have to be added. The concentrations of these 
substances as well as other additives like a buffer system can be varied. It is possible 
to optimize the composition of the cell-free expression for every protein. However, for 
all optimizations of the E. coli cell-free system at laboratory scale the firefly luciferase 
(Photinus pyralis) was used as a reporter protein. This protein was chosen, because 
not only the protein yield, but also the activity of a respective protein is really 
important. The active luciferase can be detected directly out of the cell-free reaction 
mixture. By adding a buffer to the reaction mixture, positive expression results of firefly 
luciferase can be determined qualitatively and quantitatively in a light reaction which is 
measurable with a luminometer.  
In contrast to its multiple benefits the insect cell-free reaction is far less developed 
than the in vitro expression in E. coli. This might be true, because previous 
characterization and optimization studies of the insect cell-free reaction were based 
on manual ‘one–factor–at–a-time’ methods, which are expensive and time consuming. 
In this study the insect cell-free expression systems of the two cell types Sf9 and 
High Five™ have been reproducible implemented on a robotic platform. Again the 
firefly luciferase was used as a reporter protein. The experimental design was 
performed using a statistical method (DoE) and the results were evaluated by 
multivariate data analysis (MVDA). For every insect cell type, 566 different reaction 
mixtures compositions were pipetted with the robotic workstation. This resulted in 
experimental data which could be successfully adjusted for both cell types to a second 
degree polynomial, a ‘response surface’. Furthermore, both empirical models could be 
validated by additional experiments. The results of the in vitro translation 
characterization, including the influence parameters and their interactions as well as 
their influence on the expression yield, could be quantitatively calculated and 
presented in sensitivity charts. The applicability of this new method was confirmed by 
a comparison to factors from previous studies. Therefore, the model-based 
characterization may be applied to other cell-free systems for a detailed description 
and an increase of the protein yield. 
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Cell-free expression systems are often used to produce difficult to express proteins. 
These proteins can be either toxic to living cells or even inhibit the protein expression 
machinery of the cell. Here, the cell-free expression shows a tremendous advantage 
over conventional recombinant protein expression methods. If performing a high 
number of screening experiments, using cell-free expression can save a lot of time 
and material costs in contrast to cell-based expression. In this study, E. coli cell-free 
expression has been used to provide an in vitro expression optimization for the in vivo 
protein production of the full length U1-68/70 K protein. The autoantigen U1-68/70 K is 
the dominant diagnostic marker for the autoimmune ‘Mixed Connective Tissue 
Disease’, which could not be expressed in its full length form [6]. However, it was 
possible to produce a truncated version for the use as a diagnostic marker. With the 
use of the cell-free expression screening, the results of the in vitro expression could 
be successfully transmitted to the in vivo environment and thus the snRNP protein U1-
68/70 K could be successfully produce in a soluble and full-length form in E. coli cells. 
The length and specificity of the protein was verified by Western blot analysis and an 
MS / MS approach. Furthermore, the reactivity of the protein has been tested and 
demonstrated for autoimmune diagnostics. The establishment of a cell-free 
expression system for the prediction of cell-based protein production parameters such 
as the applicability of the cDNA construct, the expression temperature or the folding 
properties can now be determined in a time and material saving manner. 
As already stated previously, the cell-free expression is the method of choice when it 
comes to the production of a large number of proteins in a small scale. To identify and 
quantify high numbers of proteins and to analyze their function in biological processes, 
microarray assays are used. Microarray systems have great potential and are for 
example implemented in multiplex diagnostics. Lyme disease, caused by several 
species of Borrelia, is the most common tick-borne disease in North America and 
Europe. In Germany each year 1 million new infections are reported. In most 
countries, a two-test approach for the diagnosis of this infection is used. This includes 
a specific ELISA followed by an immunoblot. Since this technique is very expensive, 
an alternative testing is preferred. A method for linking the before optimized cell-free 
expression to the subsequent microarray printing of various Borrelia antigens on multi-
well plates has been developed. In an E. coli cell-free system eleven immunodominant 
antigens of different Borrelia species have been successfully expressed and then 
purified. The reproducible immobilization on the microarray plates and the detection of 
antigen activity could be detected with the help of different blood sera from patients 
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suffering from Lyme disease and specific monoclonal antibodies. A comparison of the 
cell-free approach developed here to cell-based expressed, purified and printed 
Borrelia antigens confirmed the diagnostic value of the new assays. In summary, this 
approach serves as a ‘proof of principle’ for the identification of potential biomarkers 
and offers the possibility of a multiplex protein detection for diseases. 
The research in this thesis shows different types of applications of cell-free 
expression. Despite the already optimized production processes for cell-free 
expression systems and the recently significantly improved reaction yields, the 
potential for optimization of cell-free expression systems is not yet exhausted. The 
linkage between protein production and protein analysis needs to be further examined 
in future studies to integrate folding proteins or other additives in cell-free expression 
to reach integration of desired protein properties for the analysis of diseases already 
on the level of protein production. 
 
  
Zusammenfassung 
Die vorliegende Dissertation beschäftigt sich mit der Hochdurchsatzoptimierung von 
zellfreier Proteinexpression, der nachfolgenden Proteinanalytik sowie einer 
Verknüpfung dieser Verfahren. Das Forschungsergebnis trägt dazu bei die 
biochemische Proteinherstellung und -analyse zu vereinfachen und zu beschleunigen. 
Die üblichen zellbasierten Expressionsmethoden können Gen-Sequenzen, denen 
bisher keine definierte Funktion zugeordnet werden konnte, teilweise nur 
unzureichend oder überhaupt nicht darstellen. Mit Hilfe der zellfreien Expression 
können aus diesen Gen-Sequenzen Proteine mit besonderen Eigenschaften, die vor 
allem in der personalisierten Medizin und Pharmaforschung von hohem Wert sind, 
hergestellt werden. Nach der in dieser Forschungsarbeit optimierten zellfreien 
Expression in verschiedenen Zellsystemen und dem Einsatz dieser zur Expression 
von diagnostischen Proteinsystemen, wurde weiterführend auch die Proteinanalytik 
untersucht. Bei den beiden Verfahrensschritten, Proteinherstellung und 
Proteinanalytik, erfolgte eine Weiterentwicklung vom Labormaßstab zur 
Hochdurchsatzmethode, um eine höhere Anzahl von Experimenten in kürzerer Zeit 
und mit weniger Materialkosten durchführen zu können. Um die Anwendbarkeit dieser 
neuartigen Verfahren zu zeigen, wurden die Ergebnisse der zellfreien Expression mit 
bisher gebräuchlichen zellbasierten Expressionen verglichen.  
In den letzten Jahren ist vor allem in der Biotechnologie und dort im Bereich der 
Proteomik der Bedarf an einfacheren und schnelleren Verfahren zur 
Proteinherstellung gewachsen, um genetische Informationen effizienter nutzbar zu 
machen. Hierbei spielt die zellfreie Expression, mit deren Hilfe Proteine aus DNA 
Vorlagen hergestellt werden können, als sehr leistungsfähige Technologieplattform 
eine wichtige Rolle [1–3]. Sie besteht aus zwei Schritten, der Herstellung des 
Zellextrakts und der zellfreien proteinproduzierenden Reaktion. Aus drei 
unterschiedlich genveränderten Bakterienzellen des Stammes Escherichia coli 
(E. coli) sowie zwei eukaryotischen Insektenzellarten (Sf9 und High Five™) wurden zu 
Beginn dieser Arbeit Zelllysate hergestellt. Da die Proteinausbeute unter anderem von 
der Methode des Zellaufschlusses und der weiteren Verarbeitung des Zelllysates 
abhängig ist, wurden drei verschiedene Verfahren zur Zelllyse (Druckaufschluss durch 
French Press oder Zellhomogenisator bzw. Einfrieren und Auftauen) angewandt und 
im Hinblick auf die Proteinausbeute optimiert. Weiterhin unterscheiden sich die Lysate 
selbst je nach Zelltyp und Stamm im Hinblick auf die Proteinexpression. Zum Beispiel 
erwies sich die RNaseE Mutante des E. coli Stammes BL21 Star
TM
 (DE3) als sehr 
effizient für die zellfreie Proteinexpression. Die Gensequenz für das Enzym RNaseE 
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wurde hierbei entfernt und somit auch die Proteinherstellung dieses Enzyms 
unterdrückt, welches normalerweise für die Zerstörung jeglicher Fremd-mRNA 
zuständig ist. Somit erfolgt bei einem Zelllysat mit dieser Eigenschaft erheblich 
weniger Abbau der neu gebildete mRNA durch das Enzym RNAse Je nach 
gewünschtem Einsatz und Art der Proteine, wurde durch Expressionsscreenings in 
den verschiedenen zellfreien Expressionssystemen für jedes Protein die zellfreie 
Expression gewählt, die die Proteine entweder in hoher Ausbeute oder mit den 
gewünschten posttranslationalen Modifikationen produziert.  
Die Grundvoraussetzung aller Proteinexpressionen ist die eingesetzte gencodierende 
DNA-Sequenz, die während der Reaktion in das jeweilige Protein übersetzt wird. In 
dieser Studie wurden als DNA-Träger ausschließlich Plasmide genutzt. Diese 
enthielten alle das T7-Promotorsystem, welches mittels T7-RNA-Polymerase hohe 
RNA Mengen produziert und somit die Voraussetzung für eine hohe Proteinmenge 
legt. Die cDNA-Sequenzen wurden für die E. coli-Expression in den pET24d-Vektor 
und für die insektenzellfreie Reaktion in das Plasmid pDT1 [4] kloniert. Diese 
Unterscheidung zwischen den Zelltypen und die Festlegung auf diese beiden 
Vektoren hat sich in entsprechenden, zu Beginn durchgeführten Studien, als 
ausbeutesteigernd erwiesen. Die cDNA-Sequenzen der jeweiligen Proteine enthielten 
meist zusätzlich einen N- oder C-terminalen His-Tag zur spezifischen Proteindetektion 
oder -aufreinigung. Teilweise wurde auch zusätzlich ein spezieller Proteinanhang, der 
HaloTag
®
 hinter oder vor die codierende Proteinsequenz kloniert [5], um die Proteine 
nach der Expression spezifisch auf entsprechend behandelten Oberflächen 
immobilisieren zu können. 
Die zellfreie proteinproduzierende Reaktion, im Weiteren als zellfreie Expression 
bezeichnet, besteht zellunabhängig aus zwei Teilen, der Transkription und der 
Translation. Der Unterschied zwischen Prokaryoten und Eukaryoten ist der 
Expressionsort. Während in den Prokaryoten die Transkription und Translation 
gleichzeitig innerhalb der Zelle ablaufen, finden die Transkription bei Eukaryoten im 
Zellkern und die nachfolgende Translation im Zellplasma statt. Während der 
Transkription wird aus einer DNA-Vorlage eine mRNA-Vorlage erstellt, welche 
wiederum in der sogenannten Translation in eine Peptidkette übersetzt wird. Danach 
werden je nach Proteintyp und Zellart teilweise posttranslationale Modifikationen an 
die Peptidkette angehängt bzw. es findet eine Faltung der Proteine mittels 
Helferproteinen statt. Je nach gewünschter Anwendung der hergestellten Proteine 
können diese finalen Proteinmodifikationen den Ausschlag für einen erfolgreichen 
Einsatz der Proteine darstellen. Zum Beispiel wurde der Zusatz verschiedener 
bekannter Faltungshelferproteine bei der zellfreien Expression mit E. coli erfolgreich 
getestet und eingesetzt. In dieser Studie erfolgten alle E. coli-zellfreien Expressionen 
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in Form einer ‚coupled-reaction‘, d.h. dass die Transkription und Translation 
gleichzeitig in einem Reaktionsgefäß abliefen. Im Gegensatz dazu wurden die in-vitro-
Insektenzellreaktionen verbunden (‚linked-reaction‘) betrieben. Das bedeutet, dass die 
mRNA nach der Transkription im Reaktionsgefäß in ein zweites überführt wird, um 
danach die Translation durchzuführen. Vor dem Einsatz der beiden zellfreien 
Expressionssysteme zur Produktion verschiedener Proteine, erfolgte die jeweilige 
Charakterisierung und Optimierung der Reaktionszusammensetzungen. Eine zellfreie 
Expression besteht aus dem im Vorigen beschriebenen präparierten Zelllysat, 
welches unter anderem die tRNAs, verschiedene Enzyme und die zelleigenen 
Ribosomen enthält. Zur erfolgreichen Proteinexpression müssen die T7-RNA-
Polymerase, die 20 proteinogenen Aminosäuren, Energie in Form von GTP und ATP 
sowie ein energieregenerierendes System zugesetzt werden. Die Konzentrationen 
dieser Substanzen sowie weiterer Zusätze, wie z.B. eines Puffersystems können 
variiert werden. Es ist möglich die Zusammensetzung der zellfreien Expression für 
jedes zu exprimierende Protein zu optimieren. Exemplarisch wurde allerdings bei den 
Optimierungen des E. coli-zellfreien Systems, welche im Labormaßstab erfolgte, die 
Firefly Luciferase (Photinus pyralis) als Beispielprotein genutzt. Die Wahl fiel auf 
dieses Protein, da nicht nur der Proteinausbeute, sondern auch der Aktivität des 
jeweiligen Proteins eine große Bedeutung zugeschrieben wird. Die aktive Luciferase 
kann direkt aus dem zellfreien Reaktionsgemisch heraus in vitro detektiert werden. 
Durch Zugabe eines Puffers zum Reaktionsgemisch entsteht bei positiver Luciferase-
Expression eine Lichtreaktion, die mittels eines Luminometers qualitativ und 
quantitativ ermittelt werden kann.  
Im Widerspruch zu ihren vielfältigen Vorteilen ist die insektenzellfreie Reaktion bisher 
weniger gut etabliert als die in-vitro-Expression in E. coli. Dies könnte auch daran 
liegen, dass bisherige Charakterisierungen und Optimierungen der insektenzellfreien 
Reaktion auf manuellen ‚one-factor-at-a-time‘-Methoden basieren, die teuer und 
zeitaufwändig sind. In dieser Thesis wurden die insektenzellfreien 
Expressionssysteme der beiden Zellenarten Sf9 und High Five™ auf einer 
Roborterplattform reproduzierbar implementiert. Als Reporterprotein kam auch hier 
wieder die Firefly Luciferase aus den vorher genannten Gründen zum Einsatz. Die 
Versuchsplanung erfolgte mittels statistischer Methodik (DoE) und das Ergebnis 
wurde durch eine multivariate Datenanalyse (MVDA) ausgewertet. Pro Zelltyp wurden 
566 verschieden zusammengesetzte Reaktionsansätze mit Hilfe des Roboters 
pipettiert. Daraus resultierten für beide Zelltypen experimentelle Daten, die erfolgreich 
an ein Polynom zweiten Grades, eine ‚Response Surface‘, angepasst werden 
konnten. Weiterhin konnten beide empirischen Modelle durch zusätzliche 
Reaktionsansätze validiert werden. Das Ergebnis der in vitro-Translations-
Charakterisierung durch den Einbezug der Einflussparameter und deren Interaktionen 
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sowie ihres Einflusses auf die Expressionsausbeute konnte quantitativ berechnet und 
in Sensitivitätsdiagrammen dargestellt werden. Die Anwendbarkeit dieser neuen 
Methode wurde durch einen Vergleich der Einflussgrößen zu früheren Studien 
bestätigt. Daraus folgt, dass die modellbasierte Charakterisierung jederzeit auf weitere 
zellfreie Systeme zur näheren Beschreibung und Steigerung der Ausbeute angewandt 
werden kann.  
Zellfreie Expressionssysteme werden häufig dazu genutzt, schwer zu exprimierende 
Proteine herzustellen. Diese Proteine sind oft entweder für lebende Zellen toxisch 
oder hemmen den Proteinexpressionsapparat der Zellen. Hierbei besitzt die zellfreie 
Expression einen enormen Vorteil gegenüber herkömmlicher rekombinanter 
Proteinexpression. Weiterhin kann mit Hilfe der zellfreien Expression eine hohe 
Anzahl von Screeningexperimente durchgeführt werden, welche im Vergleich zu 
zellbasierter Expression viel Zeit und Materialkosten sparen. Im weiteren Verlauf der 
Arbeit wurde die E. coli zellfreie Expression dazu genutzt, durch eine in-vitro-
Expressionensoptimierung die in-vivo-Proteinproduktion des Proteins U1-68/70 K in 
seiner vollen Länge zu ermöglichen. Das Autoantigen U1-68/70 K ist ein 
dominierender diagnostischer Marker der Autoimmunerkrankung ‚Mixed connective 
tissue disease‘, der bis vor kurzem nicht in seiner vollen Länge exprimiert werden 
konnte [6]. Es war allerdings möglich eine verkürzte Version als diagnostischen 
Marker zu produzieren. Durch den Einsatz eines zellfreien Expressionsscreenings ist 
es gelungen, die Ergebnisse der in-vitro-Expression auf das in-vivo-Umfeld zu 
übertragen und damit das snRNP Protein U1-68/70 K in seiner löslichen Form in voller 
Länge erfolgreich in E. coli-Zellen zu produzieren. Die Proteinlänge und -spezifität 
konnte durch Western-Blots und eine MS/MS-Analyse verifiziert werden. Zusätzlich 
wurde die Reaktivität in der Autoimmun-Diagnostik getestet und nachgewiesen. Durch 
die Etablierung eines zellfreien Expressionssystems zur Voraussage von 
Proteinproduktionsparametern, wie z.B. der Anwendbarkeit des cDNA-Konstrukts, der 
Expressionstemperatur und den Faltungseigenschaften in zellbasierenden Systemen, 
können zukünftig die vorher genannten Parameter Zeit und Material sparenden 
bestimmt werden. 
Wie schon im Vorigen ausgeführt, ist die zellfreie Expression die Methode der Wahl, 
wenn es um die Produktion einer großen Anzahl an Proteinen in kleinem Maßstab 
geht. Um diese große Anzahl von Proteinen zu identifizieren und zu quantifizieren, 
sowie ihre Funktion in biologischen Prozessen zu analysieren, werden Assays im 
Mikroarrayformat verwendet. Mikroarraysysteme besitzen ein sehr großes Potenzial 
und werden zum Beispiel in der Multiplex-Diagnostik angewendet. Lyme-Borreliose ist 
die häufigste durch Zecken übertragene Krankheit in Nordamerika und Europa. In 
Deutschland werden jährlich 1 000 000 Neuinfektionen gemeldet. Für die Diagnostik 
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dieser Infektion wird in den meisten Ländern ein Zwei-Test Ansatz genutzt. Dieser 
beinhaltet einen ELISA gefolgt von spezifischen Immunoblots. Da diese Technik sehr 
aufwendig ist, wurde in dieser Arbeit nach einer Alternative gesucht. Durch die 
Kombination von zellfreier Expression und der Mikroarraytechnik wurde ein Verfahren 
für die Expression und das anschließende Drucken verschiedener Borrelia-Antigene 
auf Multi-Well-Platten erarbeitet. In einem eigens hergestellten E. coli-zellfreien 
System wurden elf immundominante Antigene der Lyme-Borreliose von 
verschiedenen Borrelia-Arten erfolgreich exprimiert und anschließend gereinigt. Mit 
Hilfe von Blutseren von an Borreliose erkrankten Patienten und spezifischen 
monoklonalen Antikörpern, konnten die erfolgreiche Immobilisierung und Aktivität der 
Antigene reproduzierbar auf den Mikroarrayplatten nachgewiesen werden. Ein 
Vergleich zu zellbasiert exprimierten, gereinigt und gedruckten Borrelia-Antigenen 
bestätigt die diagnostische Aussagekraft des neuen Assays. Zusammenfassend ist zu 
sagen, dass dieser Ansatz als ‚proof of principle‘ für die Identifizierung von 
potentiellen Biomarkern dient und die Möglichkeit einer Multiplex-Protein-Erkennung 
für Krankheiten bietet. 
Wie diese Arbeit zeigt, sind die Arten der Anwendung der zellfreien Expression sehr 
vielfältig. Trotz bereits optimierter Herstellverfahren für zellfreie Expressionssysteme 
und in den vergangenen Jahren erheblich verbesserter Reaktionsausbeuten, ist das 
Potenzial der Optimierung von zellfreien Expressionssysteme noch lange nicht 
erschöpft. Auch die Vernetzung von Proteinherstellung und Proteinanalyse muss noch 
weiter untersucht werden, um zukünftig durch Zusatz von Faltungsproteinen oder 
weiteren Substanzen zur zellfreien Expression die gewünschten Proteineigenschaften 
für die Analyse von Krankheiten bereits auf der Proteinproduktionsebene zu 
integrieren. 
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1 Introduction 
The objective of this work was the optimization and subsequent application of cell-free 
expression to improve protein production, where cell-based systems have natural 
boundaries. Not only the increase of protein yield, but the combination of protein 
expression and protein analysis in a high-throughput mode was a goal. Overall, an 
improvement of biochemical protein production based on this combination is desired.  
1.1 Cell-free expression 
The terms ‘cell-free expression’ or ‘in vitro protein synthesis’ are nowadays on 
everyone’s lips. Cell-free expression is a kind of protein production without living cells. 
The expression process is taking place in an artificial environment; specified as an 
“open” system [7]. This term is used, because the protein is expressed outside the cell 
without having the compartment of a cell membrane. This implies advantages and 
disadvantages. 
1.1.1 Advantages and disadvantages of cell-free expression 
The production of small quantities of proteins can be performed quickly and 
economically with cell-free expression. This leads to their adaptability to high-
throughput experiments, in which high numbers of experiments are desired. In cell-
free expression systems, no cell viability concerns are necessary. Therefore, toxic 
proteins, which would destroy the cell metabolism or simply the expression apparatus, 
can be produced. Before cell-free expression techniques were developed, biochemical 
and structural characterization of membrane proteins for example have been in its 
infancy. Nowadays, sufficient amounts of functional membrane proteins even for 
crystallography and biochemical analysis are producible [7,8]. In cell-free expression 
systems additives like detergents, metal ions, cofactors or binding partners can simply 
be added to the expression reaction. This can only be accomplished by owning the 
“open” system characteristic. Additionally, incorporating isotopic labels and non-
natural amino acids into the peptide chain of the produced proteins is easy. Even the 
simultaneous expression of more than one protein in one cell-free reaction is possible. 
For example, heterotrimers of human laminin-322 LCC domains were successfully 
produced in a cell-free system. Furthermore, the three peptide chains were formed 
and assembled in the in vitro reaction [9].  
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A disadvantage of cell-free expressions is the relatively low protein yield, depending 
on the expression system. Additionally, cell-free expression can be expensive, 
depending on the used system and if it is commercially purchased. One has to keep in 
mind, that the in vitro reaction has no sustained metabolism to convert cheap energy 
sources like sugars. Recently, glucose [10,11] or polymeric carbohydrates [12] were 
successfully used in cell-free expressions as an energy supply. Another disadvantage, 
which is solving itself by the years, is the less characterization of cell-free expression 
systems and the less usage experience in laboratories compared to organisms like 
E coli.  
1.1.2 The fundament of cell-free expression – vector cloning 
1.1.2.1 DNA and genetic engineering 
In the DNA the information about the protein sequence and its localization in the 
organism is stored. Already in 1953, Watson and Crick developed that the information 
carrier for heredity is the DNA [13]. This universal code, being identical for pro- and 
eukaryotes, only varies in the adjustment of the four different nucleotides (adenosine, 
thymine, cytosine and guanine) in codon triplets. Each of these triplets is 
corresponding to one of only 20 amino acid building blocks which form the amino acid 
sequence, being the primary structure of all proteins. Nevertheless, the use of the 
genetic code (also called ‘codon usage bias’) is variable in different organisms. This 
variability refers to differences in the frequency of the occurring codons in the DNA 
sequence. Therefore, it is important to keep in mind that the codon usage of the 
protein expressing organism should be applied for any DNA template to reduce 
expression difficulties or unwanted stops. 
The methods of genetic engineering are consisting of different basic applications such 
as isolation, replication, enzymatic modification and characterization, sequencing and 
chemical synthesis of the molecule DNA. A bacterial cell has two different types of 
DNA, the genome and a number of 50 to 100 plasmids. These plasmids are circular 
and with 3 000 to 100 000 nucleotide base pairs (bp) relatively small compared to the 
genome. Since plasmids are consisting of double-stranded DNA, they can be 
replicated on their own, but can also be integrated into the bacterial genome. They 
have a replication starting point and mostly one or two genes, which are important for 
the survival of the bacterial cell. For example, antibiotic resistance genes can usually 
be found on the plasmid DNA. By looking at the before mentioned characteristics of 
plasmids, they own the abilities for the use as DNA vectors, integrating foreign DNA 
into bacterial cells. Plasmids can be extracted from the bacterial cell and new gene 
sequences can be cloned into them in vitro. They are smaller than 10 000 bp for an 
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easy handling and by integrating antibiotic resistant genes, negative selection 
pressure can be established. Vector plasmids own an ‘origin of replication’ for a 
bacterial cell. If a transformation of the vector into other cell types is preferred, another 
‘origin of replication’ can be added optionally to the DNA sequence of the vector 
plasmid. This would enable a following transformation of the vector into another host 
cell organism. For the cloning procedure, the plasmids have to be purified and opened 
with restriction enzymes on before determined positions. The foreign DNA is 
integrated into the ‘multiple cloning site’ where every ‘restriction enzymes cutting site’ 
exists only once to guarantee the correct insertion of a DNA piece cut with the 
identical restriction enzyme. The invention of the polymerase chain reaction (PCR) 
made it possible to produce extremely high numbers of DNA sequences in vitro. The 
three basic phases of a PCR are denaturation, annealing and synthesis of a DNA 
sequence after a DNA template. It became really important to generate specific DNA 
segments for cloning or sequencing, as well as detecting the presence of specific 
genetic defects. One disadvantage is that the enzyme Taq-polymerase [14], which 
synthesizes the DNA sequence with the nucleotide building blocks, doesn’t have 
proofreading abilities and can introduce errors. If this happens early in the process, 
the false DNA is also further amplified. Another problem using PCR is the possibility of 
contamination with false DNA fragments. If this happens and the primer sequences 
can also anneal to the foreign DNA it is amplified as well. But nevertheless, PCR is 
the method of choice for producing DNA fragments in vitro [15]. In addition to the 
insertion of the coding DNA sequence also the DNA sequence for protein tags to 
simplify purification or protein analysis is preferred. After the ligation of the foreign 
DNA sequence into the plasmid sequence, the plasmid needs to be replicated. 
Therefore, a transformation into a bacterial cell is necessary. There are different 
transformation methods. A chemical method uses CaCl2 for the perforation of the cell 
wall to integrate the plasmid DNA [16]. Electroporation is another method to physically 
open up the cell wall. The analysis of a successful plasmid DNA transformation and 
foreign DNA sequence integration is performed with an analytical PCR run and a 
following agarose gel analysis. Here, the DNA sequence is analysed after its bp size. 
For protein expression in different host cells, many plasmid types were studied and 
optimised to increase protein yields. Most plasmid vectors were developed for E. coli, 
but there are also systems for Bacillus, Pseudomonas, Streptomyces, Lactobacillus 
and some others.  
1.1.2.2 Template generation: Plasmids for cell-free expression 
The choice of plasmid and the codon usage of the gene of interest correspond 
strongly to the host cell organism in which the protein is expressed originally. This is 
also true for cell-free expression, but is here more influenceable than in cell-based 
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expression. This is something one has to keep in mind when cloning a plasmid for in 
vitro protein synthesis. An alternative to plasmids are PCR-templates [1,17–19], 
because the time-consuming steps of plasmid generation, multiplication and 
purification are eliminated. For a protein expression, the plasmid or PCR-product 
template needs to contain a promoter sequence and a translation initiation signal at 
the 5’-region of the gene of interest [2,20–22]. Especially in eukaryotic cells this 5’ 
untranslated region (UTR) is important for initiation, translation and mRNA stability 
[20]. The optimization of 5’-UTRs for eukaryotic cell-free expression systems is 
described by Ezure et al. [23,24]. For stopping the expression of a protein, a 
transcription and translation stop at a selected location, a so called termination 
sequence at the 3’UTR-region is necessary [2].  
The most time consuming step while applying in vitro protein synthesis is the vector 
preparation. In order to reach high-throughput applications this step needs to be 
diminished. This can be reached through the application of PCR products instead of 
using plasmid as vectors for cell-free expression. The shortcoming of using PCR 
products is the problem of having less DNA and accordingly linear DNA instead of 
circular plasmids, which is degraded faster. This problem was solved in the past by 
either using multiply-primed rolling circle amplification [25] or applying optimized 
reaction conditions [26,27]. Thus comparable protein yields using PCR products vs. 
plasmids can be reached.  
1.1.3 Cell-free extract preparation 
1.1.3.1 Which kind of cell-free expression systems are available? 
The question of the cell type to use for cell-free expression strongly depends on the 
end product application. Though, the cell-free expression system should be similar to 
the protein origin and biochemical background to achieve good results like a high 
protein yield, the necessary protein complexity, desired downstream conditions and 
low costs [3]. Overall, every cultivatable cell type can be used for extract preparation 
and therefore protocols for preparation and optimization of cell lysates from different 
cells have been studied to establish different cell-free expression systems and to 
increase the protein expression level [2]. To date E. coli [28,29], wheat germ [30,31], 
rabbit reticulocytes [32,33], yeast [34,35] and insect cells [36] are mostly applied for 
cell-free expression. A number of unusual hosts like Leishmania tarentolae [37], 
human HeLa-cells cells [38,39], Drosophila embryo [40], Xenopus oocyte or egg [41] 
and hyperthermophilic archaeon [42] have also been successfully prepared.  
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1.1.3.2 Coupled vs linked cell-free expression 
The difference between coupled and linked cell-free expression is the expression 
template. While in coupled reactions a DNA template is used, linked systems have 
mRNA templates. This differentiation originates from the used cell systems. 
Prokaryotes are single-cell creatures which proliferate through splitting. They lack a 
nucleus and their DNA is balled into a nucleoid. This fact influences protein 
expression, because only one compartment for transcription and translation exists. 
While the transcription of the DNA takes place, the ribosomes can already start 
translation on the other end of the built mRNA. The complete process is running in the 
cytosol (Figure 1). This is where ‘coupled cell-free reaction’ comes from. In this 
expression type, the DNA is directly added into the cell-free expression system and 
after transcription and translation are over, the protein can be analyzed. This kind of in 
vitro expression is mostly applied with prokaryotic systems, but can also be adopted in 
eukaryotic systems. In contrast to prokaryotic cells, eukaryotes own a nucleus where 
the DNA is stored. Therefore, the protein production process is locally parted. The 
transcription process, in which the DNA sequence is read and the mRNA is built takes 
place in the nucleus. For the now following translation, the mRNA has to move out of 
the nucleus into the cytosol where the ribosomes can translate the nucleic acid 
sequence into a protein (Figure 1). This process is the template for the ‘linked cell-free 
expression’, where first the transcription takes place in vitro followed by a traditional 
purification of the mRNA and afterwards the translation can take place in another 
tube. 
 
Figure 1: Prokaryotic (a) vs eukaryotic (b) cell: www.piercenet.com (thermo scientific) 
 
1.1.3.3 Advantages and disadvantages of the different cell systems 
The ‘protein synthesis machinery’ of different cell types may constitute of various 
cellular components (e.g. ribosomes, initiation and elongation factors, metabolic 
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enzymes) or co-factors (e.g. chaperones, foldases) which influence protein 
expression, folding and modifying proteins [2].  
The fastest, most effective and cheapest system to date and therefore mostly used is 
the cell-free expression in E. coli. It is high-throughput compatible, tolerant to 
auxiliaries and the proteins expressed by this system are suitable for structural 
analysis [43,44]. High amounts of extract can be prepared easily since E. coli cells 
can be fermented at large scale. For the use of only a few expressions, E. coli cell-
free extracts are commercially available [1]. Furthermore, well-established tools for 
modifications are available since E. coli cells are studied well [3]. The shortcomings of 
this system are in heterologous protein expression. E. coli cell-free system may 
produce truncated proteins, protein fragments or insoluble proteins and eukaryotic co- 
and posttranslational modifications are not possible. Their codon usage bias is 
different to eukaryotic cells, what can cause the aforementioned problems (see 
paragraph 1.1.2.1). It is difficult to generate folded eukaryotic proteins in this system 
[1,17,45,46].  
Eukaryotic cell-based systems are required for the expression of correctly folded 
heterologous proteins which are also suitable for functional studies, because of 
owning post-translational modifications. But one has to keep in mind that they are less 
productive and more expensive than E. coli cell-free expression systems [41,42]. 
Rabbit reticulocytes and insect cells own the highest post-translational versatility for 
heterologous protein expression and are both commercially available. Furthermore, 
insect cells are a fast growing platform and their extract preparation in contrast to 
other eukaryotic cells is easy and quick [23]. Their disadvantage is that cell cultivation 
is expensive and time-consuming. Furthermore, they are non-mammalian cells and 
therefore not owning mammalian post-translational modifications, but still the insect 
cells can built many types of posttranslational modifications which have been 
functionally similar to authentic proteins [47]. Shortcomings of rabbit reticulocytes are 
that they have a low efficiency [48], are not able to glycosylate proteins [49] and their 
production is highly complex, because a manipulation of animal tissue is required. 
Furthermore, they often co-express unwanted byproducts. The highest protein yield 
even for complex proteins in eukaryotic cells is possible with wheat germ. They are 
relatively cheap compared to other eukaryotic cells [48], commercially available and 
even high-throughput compatible [50]. The disadvantages of this system are the little 
genetic modification tools, the lack of mammalian specific protein modifications and 
the laborious extract preparation [3].  
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In many studies cell-extract preparation methods from different cells were optimized, 
but it is still difficult to eliminate protein or nucleic acid degradation by proteases or 
nucleases. To date, inhibitor substances can suppress the activity of the natural 
present proteases and nucleases in cell extracts, but not eliminate them. In 2001, the 
E. coli PURE (Protein synthesis Using Recombinant Elements) system has been 
made. It constitutes of an in vitro reconstituted mixture composed of purified 
components. All 32 recombinantly produced components are linked to a histidine 
(His)-tag. Therefore, the possibility of an easier purification of the target protein using 
affinity chromatography is warranted. It still is a very expensive in vitro protein 
production system, but a valuable tool for studying the translation process under 
predefined conditions [51].  
1.1.3.4 A short overview: How to make cell-free extracts 
The basic steps of a cell-free extract preparation are shown in Figure 2. First, the cells 
need to be grown in a cell culture, followed by the cell harvest while they are still 
having a good viability and productivity, which is warranted while the cells are in a 
rapid growing phase [52,53]. The cell lysis depends on the 
cell type and can be performed in different ways. For 
example, E. coli cells are traditionally opened by a French 
press or high pressure homogenizations. Whereas 
eukaryotes only need liquid nitrogen in nitrogen bombs or a 
simple freeze and thawing method to be ruptured [23]. In 
the following centrifugation steps unwanted substances are 
eliminated, which also dependents on the extract type 
prepared. For E. coli cells a following incubation step can be 
performed which “activates” the extract. Recently, a new 
method for E. coli extract preparation was published, 
reducing time and effort [54]. Overall, the extract should be 
handled with care and be cooled during the complete 
process in order to prevent proteases and nucleases to reduce the expression abilities 
of the different extract types. At the end, a quick freezing step in liquid nitrogen and 
the storage at -80°C is essential.  
1.1.4 Cell-free reaction composition 
Cell-free gene expression is a modern method of protein production. It is possible to 
assemble only the desired protein without having to deal with the protein production 
system especially with the metabolism of the cell. Still, the prepared cell lysate is the 
main substance used in cell-free expression. Up to the extract preparation method 
Figure 2: Cell extract 
preparation process 
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important proteins for the following expression can be preserved and don’t have to be 
added additionally. The in vitro expression systems are using the transcription and 
translation apparatus of the lysed cells. The most literally described and laboratory 
employed cell-system is still the E. coli system. The first and most cited paper about 
E. coli extract preparation and reaction composition is the publication of Pratt [55] from 
1984. It explicates the coupled transcription and translation system derived from 
Zubay et al. [56] and firstly introduces the E. coli S30 extract which is named after the 
centrifugal step with 30 000 x g after cell rupture of the E. coli strain MRE600. Since 
then many improvements of the S30 extract system have been realised. For example 
in 1996 Kim et al. [57] introduced a new preparation method with condensed E. coli 
extract for higher protein yields, using the E. coli strain A19. Nowadays, every 
research group applies their own cell-free expression method by changing the 
preparation method slightly for individual needs. In 2004 Swarz et al. summarized the 
whole process of extract preparation and cell-free expression with E. coli cells in 
Methods of Molecular Biology still using the E. coli strain A19 [58]. The production of 
E. coli extracts from a different strain was published by Kigawa et al. in 2004 [59]. The 
specialisation went on to prepare extracts suitable for membrane protein expression 
[60]. The selective mutation of E. coli strain A19 and BL21 to repress RNA-degrading 
enzymes and therefore improve cell-free expression yields was also accomplished 
[61,62]. Decreased temperatures while incubating E. coli cells are known to improve 
productivity as well [63] because the RNAse activity are decreased. An iodoacetamide 
treated E. coli extract can efficiently introduce disulfide bonds into the expressed 
proteins [64]. Further on the improvements of the E. coli extract moved to a simplified 
and cost effective S12 system, which is supposed to include higher yields than the 
S30 extract [54]. In the new method, only a centrifugal step with 12 000 x g was 
applied in order to achieve more productivity and consistency of the extract. With this 
new method, different E. coli strains can be used. For example the BL21 Star™ (DE3) 
strain contains a mutation in the gene encoding RNaseE (rne131), which is one of the 
major sources of foreign mRNA degradation. Using this strain stabilizes the in vitro 
expression newly transcript mRNA which can lead to higher protein yields. The BL21 
Rosetta strain is also optimized for protein production. It contains extra tRNAs for 
rarely used codons in E. coli in order to enhance the express results of mammalian 
proteins. In this study, both of the before mentioned strains were used for E. coli cell-
free expressions. 
Different reaction schemes are accomplished with coupled cell-free reactions. The 
continuous exchange cell-free system also known as the ‘continuous flow system’ was 
first introduced by Spirin in 1988 [29]. Furthermore the continuous exchange [65] and 
hollow fiber system [66] as well as a bilayer system were established [67]. But still the 
batch system is the most applied and for use in parallel, multiplexed and rapid protein 
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expression experiments appropriate system. The standard reaction mixture has only 
slightly changed since Pratt [55]. But many trials have been made to improve the 
secondary energy system to regenerate ATP throughout the cell-free expression. 
Hence, this has turned out to be the most critical reason behind the short duration and 
the low protein yields [68,69]. The improvements in energy supply make a wide 
stretch from fed-batch wise addition of energy sources and magnesium ions [69] over 
pyruvate as an energy source that does not accumulate inorganic phosphate [68]. 
With the invention of the pyruvate/CoA/NAD/oxalate (PANOX) system, which uses the 
addition of the cofactors NAD and CoA and the E. coli intrinsic enzymes pyruvate 
dehydrogenase (PDH) and phosphotransacetylase (PTA) to elongate the cell-free 
reaction as well as sodium oxalate to retard the non-productive degradation of 
phosphoenol pyruvate (PEP) [70], the first step of higher yield was set. Further 
investigations were made to use glycolytic intermediates as energy sources. It has 
been shown that glucose-6-phosphate, fructose-1,6-bisphosphate and 3-
phosphoglycerate serve as efficient and less expensive energy sources [70,71]. 
Glucose itself could only be utilized, if the pH of the reaction is not decreasing during 
the in vitro protein synthesis [10]. Kim et al. used glucose as an energy source by 
employing an appropriate buffer system and the optimized S12 extract [72]. Protein 
synthesis in cell-free reactions could also be prolonged using a dual energy 
regenerating system. Creatine phosphate and creatine kinase as well as glucose were 
used to expand in vitro translation to 3 h with a 2-3 times higher protein yield in 
contrast to a single energy system [73]. All methods for energizing cell-free protein 
synthesis were reviewed by Kim and Kim 2009 [74]. A further improvement of the 
batch reaction was the application of large scale cell-free reactions [75,76].  
1.2 Overview of protein analysis after cell-free 
expression 
The analysis of protein structure and function keep science occupied since a long 
time. But the development of efficient purification strategies, with which a single 
protein could be purified out of protein mixtures and the revolutionary techniques of 
protein analysis, enabled our understanding of protein structure. Still protein analysis 
after cell-free expression can be challenging by finding a small amount of protein in a 
higher concentrated protein mixture like the cell-free expression premix. The 
traditional method of [
35
S]methionine addition to the cell-free expression reaction and 
incorporation into the expressed protein allows the detection of the desired protein by 
autoradiography. Due to high costs, regulations, radioactive exposure, waste and 
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disposal issues many researchers are not executing this method anymore. Hence, a 
need for different new detection methods exists. 
1.2.1 Gel-based methods 
1.2.1.1 SDS-PAGE 
In general, for separation of protein mixtures according to their molecular weight, 
SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) is used. A 
linear relationship between the logarithm of the molecular mass and the migration 
routes of the SDS-polypeptide-micelles in certain areas is obtained. The use of protein 
standards can determine the molecular weights of the Coomassie stained proteins. 
However, Coomassie stained SDS-Pages detect all proteins and are therefore 
unsuitable for cell-free expression protein detection, because too many bands appear. 
Since cell-free expressed proteins are existent in low amounts in the expression 
mixture their detection is challenging. To date, the incorporation of a lysine-charged 
tRNA that is labeled at the ε position of the lysine with a fluorophore BODIPY®-FL into 
the emerging protein can be added to the cell-free reaction. This FluoroTect™ 
GreenLys in vitro Translation Labeling System (Promega GmbH, Mannheim) can be 
purchased and used for fluorescent labeling of proteins. After a SDS-PAGE 
electrophoresis, the nascent protein can be detected with a fluorescent scanner. 
1.2.1.2 Western Blot 
Western Blotting is another method of choice. In doing so, the separated proteins from 
the SDS-PAGE gel are electroblotted onto a nitrocellulose membrane. In the following 
an immune detection with two antibodies is attached. The primary antibody is a 
specific antibody to the protein which should be detected. The secondary antibody is a 
labeled antibody, which binds specifically to the first antibody. This method has a 
higher specificity than SDS-PAGE colored with Coomassie and is therefore a better 
choice for the detection of cell-free expressed proteins. But still, due to the specificity 
of the primary mAb the detection sensitivity can be too low. Therefore, a specific 
Western Blotting method for cell-free reactions was introduced by Promega. It is the 
Transcend™ Chemiluminescent Non-Radioactive Translation Detection System 
(Promega GmbH, Mannheim), which relies on the incorporation of a charged ε-labeled 
biotinylated-lysine-tRNA complex into nascent proteins during translation. Proteins 
can be visualized in a western blotting format by binding Streptavidin-AP or 
Streptavidin-HRP as a primary antibody and followed by colorimetric or 
chemiluminescent detection. With this method a similar sensitivity to the 
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autoradiographic detection with [
35
S]methionine incorporation can be achieved. 
Therefore, radioactivity in the protein detection after cell-free reactions is eliminated.  
1.2.2 Mass spectrometry (MS) 
With the before mentioned methods, the protein weight and therefore a characteristic 
can be approximately determined or compared. Still, for a more detailed protein 
detection, the molecular weight needs to be determined accurately. Mass 
spectrometry represents an analytical technique for determining the mass to charge 
ratio of ions under high vacuum. The discovery and application of Matrix assisted 
laser desorption/ionization (MALDI) as a gentle ionization method, made the transfer 
of larger intact biological macromolecules like proteins in the gas phase and thus their 
mass spectrometric analysis possible. When using MALDI the exact mass of 
biological molecules can be determined and their chemical composition can be 
verified. If the amino acid sequence is known, it is possible to construe from the 
difference between the calculated and the measured mass of a protein directly to the 
post translational modifications. In addition, unknown protein samples can be quickly 
and easily identified directly after proteolytic cleavage, based on the exact masses of 
the released peptides using a sequence database comparison [77].  
1.2.3 High-throughput screening protein analysis 
1.2.3.1 Protein specific spectroscopic methods 
1.2.3.1.1 Fluorescence 
The family of fluorescent proteins is originating from marine organisms. These 
organisms from coral reefs are characteristic for displaying bright fluorescence in 
almost the entire visible spectrum (450 nm to 655 nm). The Green Fluorescent Protein 
(GFP) from Aequorea victoria is the most famous and most studied fluorescent protein 
[78]. The fluorescent nature of this protein can be used as a reporter protein for cell-
free expression, because it is always detectable against the protein background. 
1.2.3.1.2 Luminescence 
Synthesized firefly luciferase from Photinus pyralis is detectable in a protein mixture 
using a luciferase assay substrate and a following luminescence measurement. In the 
Firefly Luciferase assay, the addition of luciferin, ATP and O2 converts luciferase and 
its cofactor Mg²
+
 to oxyluciferin, AMP, PPi, CO2 and measurable luminescence 
emission [79]. Hence, this protein detection method can also be used in solution, right 
after the expression reaction. 
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1.2.3.2 Protein Microarray 
Array systems are analytical systems which allow a large number of simultaneous 
measurements in one experiment. Samples are placed in an array format in a defined 
manner. A microarray is the miniaturized format allowing a highly parallel 
implementation of experiments. A protein microarray can identify and quantify a high 
number of proteins in a single experiment. Therefore, with a protein microarray 
expression studies, as well as global interaction studies and functional studies can be 
analyzed. The outstanding strength of the microarray technology is the high sensitivity 
of the measurements and on the other side the possibility to determine dozens to 
hundreds of relevant experimental parameters from extremely small samples [77]. The 
array systems are characterized by two points, on the one hand, the high degree of 
parallelism and on the other hand the extreme reduction of the analyte detection area. 
In many cases, protein microarrays are used for the analysis of antigen-antibody 
interactions. In an array a plurality of antigens is immobilized on a microarray surface 
and then detected by a labeled antibody.  
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2 Motivation and Research Proposal 
For industrial processes in the biotechnological field, which traditionally are divided 
into upstream and downstream applications, each part of the process is still 
characterized and optimized separately. The upstream part includes genetic 
engineering and bacterial or mammalian strain development. The optimization of 
fermentation processes, involving feed strategies as well as media composition is also 
embedded. The downstream processing starts with the cell harvest and include 
product purification. Nowadays, research and development has recognized the need 
for combining the characterization and optimization of the two parts in order to 
integrate development of sections within the overall process. However, with 
‘established’ approaches in process development often based purely on experience 
and sequential experimentation, integration has shown not to be feasible. The 
development of high-throughput methods enables faster and material-saving 
processes. These methods include biochemical, genetical and pharmacological tests, 
automated on liquid handling stations for a faster and reproducible performance. 
Originally, high-throughput methods were used for target screening in the 
pharmacological industry, but are now applicable for all kinds of research projects. 
One of the major challenges under this methodology of process optimization is the 
minimization of processes to high-throughput modifications, including a robotic 
implementation as well as an application improvement and optimization of the single 
process steps. The optimization of the complete process can only be conducted when 
the combination of the upstream and downstream part during the optimization is 
aspired. The following scale up of optimized process parameters therefore always 
includes upstream and downstream aspects (Figure 3). In the area of upstream 
processing, cell-free expression techniques recently came into the picture. They are a 
fast expression tool for small quantities of proteins, and therefore ideal for screening 
experiments. The cell-free expression systems are also complementary for diverse 
cell types. The most used and investigated cell type is E. coli, but also insect cells, 
wheat germ or even mammalian cells are proving promising results. For example 
insect cells own the ability to express heterologous proteins with post-translational 
modifications. Therefore, the cell-free expression performance of insect cells 
comprises lots of new features over E. coli. However, they are not as well established 
as E. coli systems. In high-throughput process optimization, data generation using a 
statistically relevant design of experiments is important. Well-designed approaches 
enable robustness of the system and description of experimental sensitivities. 
Furthermore, statistical data analyses will provide interaction quantification and 
reliable predictions for optimal substance concentration ranges as well as highlighting 
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influencing factors and predicting substance interactions. In the following, the 
characterization of two insect cell strains on behalf of their capability of being a cell-
free expression system are tested and confirmed by a model based analysis (for 
further reading: “High-throughput characterization of an Insect cell-free expression”).  
After enhancing cell-free reaction systems with high-throughput screening and 
implementation on robotic platforms, the resulting systems are usable for screening 
and improving cell-based expression. Many proteins are hard to express because they 
are toxic to the cell metabolism. Therefore, the combination of high-throughput 
parameter optimization and transfer to cell-based expression is a valid approach for 
folded and soluble difficult-to-express proteins. With cell-free expression, variables 
such as the comparison of eukaryotic or prokaryotic systems, requirements for 
auxiliary factors (e.g. the addition of chaperones, detergents or cofactors) or protein- 
and process-specific (e.g. temperature, time) can be estimated [80]. However, the full-
length expression of the autoantigen U1-68/70 K has not been reported in literature so 
far. In the publication: “Soluble full-length expression and characterization of snRNP 
protein U1-68/70 K”, the cell-free expression optimization of U1-68/70 K provides an 
example for the adaptability of the cell-free systems in screening experiments and 
shows that scale up is both manageable and process parameters are transferable. 
The last and most important challenge is the linkage of upstream to downstream 
processes. By linking cell-free expression to microarray diagnostics, two high-
throughput methods were combined, eliminating the laborious and time-consuming 
steps of cell-based protein expression and subsequent purification (“Cell-free 
expression of recombinant antigens of Borrelia burgdorferi and microarray-based 
multiplex detection using different patient sera”). Cell-free expression and microarray 
technology are already linked for applications, such as biomarker detection for 
diagnosis of autoimmune disease, immunological studies, vaccine development, 
protein-protein interactions and toxin detection. However, the linking of these two 
high-throughput methods are currently accomplished by DNA printing and a 
subsequent protein expression on the microarray surface. Therefore, the 
comparability to protein microarrays is challenging. Printing DNA molecules instead of 
proteins is evidently different. The reproducibility of on-chip expression may limit the 
use of this technology in commercial diagnostics. The possibility of rapid and cost-
reduced biomarker screening to improve the protein conditions for printing may be 
possible. An advanced question is the comparability between arrays developed on the 
basis of cell free expression and those manufactured by the large-scale compatible 
cell-based variant. 
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Figure 3: Concept of research proposal for this thesis. 
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This paper describes the reproducible implementation of two insect cell-free 
expression systems on a robotic platform. The characterization of the in vitro 
translation process included experimental planning by statistical design of 
experiments (DoE) and visualization of the parameter influences on the expression 
yield as well as the fit of the experimental data to quadratic response surface models 
by multivariate data analysis (MVDA). The results were compared to previous studies, 
which confirmed the applicability of the new method. 
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In this study, expression parameters such as the application of the cDNA construct, 
the expression temperature and folding properties for the cell-based expression in 
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In this paper, we established a procedure for the cell-free expression and subsequent 
printing of different Borrelia antigens onto several multi-well microarray plate surfaces. 
The eleven immunodominant antigens of Lyme borreliosis from different Borrelia 
species proteins could be reproducibly detected on the microarray plates. This 
approach serves as a proof of principle for the identification of potential biomarkers 
using cell-free expressed proteins. 
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Abstract 
Cell-free protein expression is a promising tool for improving protein specific 
expression techniques. Despite their advantages, Insect cell-free expression systems 
are not as well established as Escherichia coli cell-free systems. In most studies, 
characterization and optimization strategies are based on manual ‘one factor at a time’ 
investigations that are expensive and time consuming. In this paper, two insect cell-
free expression systems (Sf9 and High Five™) were reproducibly (CV=2.9%) 
implemented on a robotic platform with integrated analytics. All experiments were 
planned by statistical design of experiments (DoE) using central composite designs 
and analyzed by multivariate data analysis (MVDA). Quadratic response surface 
models were fitted to the experimental data and model predictivity was validated 
successfully for both insect cell types. The characterization of the complete in vitro 
translation process included quantification and visualization of the parameter 
influences on the expression yield and the robustness of the systems. The results 
were compared to previous studies, which confirmed the applicability of the new 
method. In the future, yields from insect cell-free expression can be enhanced using a 
comprehensive system characterization based on optimally designed high-throughput 
screenings on robotic systems. 
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1 Introduction 
In the growing field of proteomics there is an increasing demand for purified 
recombinant proteins for structural and functional studies. However, the adaptation of 
cell-based protein expression for high-throughput procedures is difficult and laborious 
[46,80]. Cell-free expression is a promising solution to this bottleneck. It offers the 
expression of large numbers of proteins in a short time frame and examination of 
protein-specific reaction conditions, for example co-translational or post-translational 
modifications, which support protein folding or solubilization [1]. 
Today there are different well-established sources of cell lysates, reaching from E. coli 
over wheat germ, yeast, insect to mammalian cells [44,81,82]. The choice of system 
depends on the biochemical nature of the desired protein. Intrinsic enzymes present in 
insect cell lysates are advantageous for many types of eukaryotic-specific post-
translational modifications [47]. Additionally, extract preparation is easy and quick. 
Consequently, the insect cell in vitro expression system appears to be the “fastest 
growing cell-free expression platform” [3]. At the same time, however, insect cell-free 
expression systems are not as advanced as can be found for E. coli cell-free systems 
[49,83,84] consequently leading to a lower performance in terms of productivity than 
found in in vitro expression of E. coli lysates [44]. Characterization and optimization of 
insect cell-free expression systems is still conducted by changing ‘one-factor-at-a-
time’, a laborious and time consuming procedure where no substance interactions 
within the cell-free reaction can be analyzed. Optimization procedures have already 
been conducted to the lysate composition, preparation of extracts from genetically 
engineered cells, the choice of the regenerating energy system and the DNA template 
[2]. Particularly, the insect cell-free lysate production and reaction substance 
composition was characterized and optimized by Ezure et al. [23] and Sato et al. [24] 
with one-factor-at-a-time experimentation. Sato et al. [85] developed the direct input of 
the mRNA into the insect cell-free translation reaction without any purification in order 
to pave the way for high-throughput screening (HTS) experiments. 
HTS would allow for a thorough characterization of the reaction substance 
composition in an insect cell-free system using modern robotic platforms for 
automated experimentation combined with model-based analysis. With data based on 
a statistically relevant design of experimental points, the robustness of the system and 
the sensitivities can be described. Influencing factors can be highlighted and 
furthermore, statistical data analysis provides interaction quantification and reliable 
predictions for optimal substance concentration ranges [86]. 
In this study, we successfully and reproducibly implemented a well-designed HTS for 
insect cell-free expression on a robotic pipetting platform. For the linked insect cell-
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free expression this approach included transcription and translation, and the protein 
analysis. The generated data was fitted to a response surface model and analyzed by 
MVDA, providing a remarkable system characterization of the insect cell-free 
translation reaction. Based on the validated model, the optimal concentration of each 
single substance in the insect cell-free expression and their interactions could now be 
predicted for the two insect cell-free lysates from Sf9 and High Five™ cells. This new 
approach significantly extends the results from the cited previous linear studies. In the 
future, this approach can be used for optimization of in vitro expression techniques for 
different cell systems. 
 
2 Material and Methods 
2.1 Materials. HEPES, DTT, adenosine triphosphate (ATP), amino acids (AA), cytosin 
triphosphate (CTP), EGTA, glycerine, glycylglycine, guanosine triphosphate (GTP), 
magnesium acetate (MgO(Ac)2), potassium acetate (KOAc), uracil triphosphate (UTP) 
were purchased from Carl Roth GmbH + Co. KG (Karlsruhe, Germany). Creatine 
phosphate (CP) and spermidine were from AppliChem GmbH (Darmstadt, Germany). 
Creatine kinase (CK) in a specific activity of 508 U/mg (Lot. 12861621) and transfer 
ribonucleic acid (tRNA) from baker's yeast were obtained from Roche Diagnostics 
Deutschland GmbH (Mannheim, Germany). RNAse Inhibitor RNasin® (40U/µL) and 
Steady-Glo® Luciferase Assay System were from Promega GmbH (Mannheim, 
Germany). Firefly Luciferase/Photinus Lampyris (recombinant) for calibration of 
Steady-Glo® Luciferase Assay System was purchased from PJK GmbH 
(Kleinblittersdorf, Germany). 
2.2 Molecular basics. For all Insect cell-free expression reactions the plasmid pF25A 
ICE T7 Flexi Vector (Promega GmbH, Germany - GenBank
®
 accession no. 
EU754721) implementing the luc+ gene [87] was used. The vector included a T7 RNA 
polymerase promoter, a 5’ and 3’ UTR sequence and a poly adenosine tail. 
2.3 Cell culture conditions. Spodoptera frugiperda insect cells (Sf9; IPLB-SF-21-AE) 
[88] and High Five™ (BTI-TN-5B1-4) (Trichoplusia ni) insect cells (LifeTechnologies 
Corporation, Germany) [89] were grown in HINK'S TNMFH (SAFC®Global) 
supplemented with 10 % FKS at 27°C in adherent cultures. For the following 
suspension cultures Gibco® Express Five® Serum Free medium supplemented with 
4 mM L-glutamine in Ex Cell ® 420 (SAFC®Global) for Sf9 cultures were used for 
higher cell densities prior to extract preparation. All media components were 
purchased at Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany). 
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2.4 Preparations for Insect cell-free expression. The insect cell cultures were 
harvested after reaching the exponential growth phase (10
6
 cells/ml), washed and 
resuspended to a density of 1.5x10
8
 cells/ml. Insect cell extract was prepared as 
previously described [23] and stored at -80°C until further use. The above-mentioned 
plasmid was transcribed with 0.5 U/µl T7 RNA polymerase (Promega GmbH, 
Germany) in transcription buffer [90] using 16 mM MgO(Ac)2 as Mg
2+
 source and 
incubated at 37°C for 3 h. For the purpose of a high-throughput application, the mRNA 
was not purified. The absorbance at 260 nm and 280 nm was measured to determine 
the purity and existence of the mRNA in the transcription buffer before and after the 
reaction. The transcription mixture was directly used or stored at -80°C. 
2.5 The response surface modeling approach. Response surface modeling is a 
useful tool for empiric modeling and predicting a response of different input variables 
with statistical techniques [91]. It is able to specify the relationships among the 
response and the input factors. Response surface modeling includes the design of an 
experimental measurement series of the response, the process of developing a 
mathematical model with the best fit, finding optimal input variable values producing a 
maximum response and representing direct and interactive effects of process 
parameters. For the DoE, the central composite design is one of the most popular 
designs. It is a full-factorial design combined with a central composite design star, 
additionally including three center points. Therefore, all combinations are 
systematically varied, resulting in 2
k
 factorial design points, several center points and 
2
k
 axial star points. The distance between the center of the design space to a star 
point is α. This DoE allows for the detection of nonlinearities and interactions in the 
factor-response-relationship. The here described characterization experiments are 
based on a central composite faced design (α=1.0) with three levels for each factor, 
three center points and a duplicate determination of all measurements (see Figure 1). 
For the characterization of the reaction substance composition in an insect cell-free 
system all additives of the translation premix, besides mRNA, insect cell-free extract 
and the protease inhibitor were investigated by the experimental design. Insect cell-
free extract and mRNA were not included, because both are containing variable 
substances, depending on cell batches. To handle this variability, the insect cell-free 
extracts originated from one batch. Furthermore, the same mRNA preparation was 
used for one experimental setup. The unpurified mRNA still includes Mg
2+ 
from the 
transcription reaction. It is experimentally added to the translation mixture. The 
protease inhibitor was directly given in an appropriate concentration to the insect cell-
free extract for stabilization.  
A number of 566 experiments was generated by the DoE software Modde 8 
(Umetrics, USA) varying the twelve translation premix substances within reasonable 
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preset ranges, expanding limitations from [92] (Table 1) and including repeat 
determination of each setup. The experimental order was randomized to exclude any 
regional effects. For a general first approach, a smaller number of experiments would 
have been possible, but in order to assure a good coverage of the design space and 
to obtain a robust model even in case of many outliers, the highest number of 
experiments possibly performable within one week was chosen. The same 
experimental design was applied to Sf9 and High Five™ insect cell-free extracts.  
 
 
 
 
 
Figure 1: A typical face-centered composite design for three factors 
 
Table 1: Translation premix components with the corresponding concentration range; lower and upper 
limits for DoE 
translation premix 
component 
concentration range limits 
HEPES-KOH (pH 7.9) [mM] 20 50 
ATP [mM] 0.1 2 
GTP [mM] 0.1 2 
DTT [mM] 0.2 5 
tRNA [mg/ml] 0.01 0.5 
KOAc [mM] 50 150 
MgO(Ac)2 [mM] 1 3 
EGTA [mM] 0.1 10 
AA [mM] 0.01 0.1 
CP [mM] 1 100 
creatine kinase  
508 U/mg (in 0.25 M pH 7.4 
Glycylglycine) 
10 mg/µl 
(0.005 U/µl) 
404 mg/µl 
(0.20 U/µl) 
RNase Inhibitor [U/µl] 0.3 0.65 
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2.6 Implementation of the Insect cell-free reaction on a robotic platform. For a 
study of 566 experiments as investigated here, pipetting with a robotic platform is 
preferred and therefore the platform ‘Freedom Evo’ (Tecan, Crailsheim, Germany) 
was used. The robotic workstation was equipped with a carrier cooling rack to control 
the temperature during pipetting, a robotic manipulator arm to move the microtiter 
plates, two incubators with integrated shaking function, a liquid handling arm (LiHa) 
and an Infinite microwell plate reader. Two dilutor volumes (1000 µL and 250 µL 
capacity), each connected to four tips of the before mentioned LiHA were used. More 
information about robotic systems can be accessed in former publications of our 
reseach group [93–95]. Since viscosity and ionic strength influence the pipetting 
process, liquid classes for every stock solution of the twelve translation premix 
substances were established and calibrated according to procedures described in 
[96]. Up to three different stock solutions per component were used to adjust the final 
concentrations. Using a dilutor with a capacity of 250 µl, the minimal pipetted volume 
is restricted to 1 µl when aiming at high accuracy. The tips of the liquid handling arm 
were washed and sterilized with 70% ethanol after finishing a pipetting step with a 
specific substance. Pipetting high sample numbers on a robotic platform and intensive 
intermediate cleaning of the pipetting tips can last 12-24 hours, therefore all 
substances were cooled down to approximately 9°C in the carrier cooling rack (Tecan, 
Crailsheim, Germany). 
Prior to the implementation of insect cell-free reaction on the robotic system (Figure 2) 
the stability of the translation premix, the transcribed mRNA and the insect cell lysate 
and its influence on the following expression performance were determined 
separately. All components of the translation premix were pipetted together and 
incubated at 9°C. After different time periods up to 18 h, samples were taken and the 
mRNA and insect cell-free extract were added. The cell-free expressions were 
incubated at 27°C for 3h and their protein yields were compared. The stability of the 
mRNA and insect cell-extract at 9°C at different times up to 40 minutes were tested in 
the same way. Furthermore, the influences of different mixing conditions on the 
expression yield were checked. The mixing of the insect cell-extract after thawing and 
the mixing step immediately before the cell-free expression including the translation 
premix, the mRNA and the insect cell extract were investigated. It was distinguished 
between no mixing, gentle mixing or excess mixing using a pipette and mixing on a 
vortex mixer. After the mixing step, the insect cell-free expressions were incubated at 
27°C for 3h and the protein yields of firefly luciferase were compared.  
For all experiments on the robotic system 96-Well Half Area White Flat Bottom 
Polystyrene NBS™ Microplates (Corning, NY, USA) were used. The overall volume of 
the insect cell-free translation was 50 µl, consisting of 40% translation premix, 10% 
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mRNA and 50% insect cell-free extract. The translation premixes consisted of twelve 
premix substances (Table 1). The insect cell-free extract was thawed immediately 
prior to the translation reaction and a concentration of 0.1% [v/v] protease inhibitor 
was added. After pipetting the different translation premix compositions, mRNA and 
insect cell extract were added and the insect cell-free reaction was incubated at 27°C 
for 3h. 
 
Figure 2: Flow diagram of the insect cell-free expression characterization combined with a model-
based approach. 
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2.7 Luminescence assay. Synthesized firefly luciferase from Photinus pyralis (EC 
1.13.12.7) was detected in HTS format using the Steady-Glo
®
 Luciferase Assay 
System (Promega GmbH, Germany) according to manufacturer’s instructions. In the 
Firefly Luciferase assay, the addition of luciferin, ATP and O2 converts luciferase and 
its cofactor Mg²
+
 to oxyluciferin, AMP, PPi, CO2 and measurable luminescence 
emission [79]. Since ATP and Mg²
+
 as well as the chelating agent EGTA are existent 
in different concentrations in the translation premix, their influence on the assay was 
determined beforehand. For the firefly luciferase yield calculations, the calibration 
curves also included the three different EGTA and Mg
2+
 concentrations, resulting in 9 
different calibration curves. Luminescence results were measured and data translation 
performed before use in model-based data analysis. 
2.8 Multivariate data analysis and model validation. The luminescence assay 
results for Sf9 and High Five™ were both separately fitted to an empiric quadratic 
model, created with the ‘Model-Based Calibration Toolbox’ in Matlab (R2011a, 
Mathworks, Germany). Equation 1 shows the regression fit of an n-variate quadratic 
function of m responses z1, ..., zm with x1, x2, ..., xn as the n selected factors for 
expression description and zi the response value to a specific factor setting x1i,x2i, ..., 
xni for all 1≤i≤m. 
zi=a1+b1*x1i+b2*x2i+…+bn*xni+c1*x21i+c2*x22i+…+cn*x2ni+d1,2x1ix2i+d1,3x1ix3i+…+dn-1,nxn-
1,ixni 
Equation 1: Regression fit of n-variate quadratic function 
The parameter a1 is an added constant like an intercept term in linear regression. The 
values of the parameters bk for 1≤k≤n display the magnitude of linear influence of the 
factors xk. The values of the parameters ck with 1≤k≤n quantify quadratic influences of 
the factors xk and the mixed effects/interaction terms of two-components are 
quantified by the parameters d12 to dn−1,n. For a better fit of the model, outliers were 
eliminated based on the linearity of the N-probability plot. For Sf9 only two outliers 
were found, whereas for HighFive™ six data points were eliminated. A Box Cox 
transformation of the data was applied. For model validation 15 random experiments 
were predicted within the design space, including one replicate each, and 
experimental data was compared with the RSM results. 
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3 Results 
The focus of this study was the implementation of the insect cell-free expression on a 
robotic platform and the characterization of the reaction substance composition in an 
insect cell-free system using a model-based analysis.  
3.1 Implementation of insect cell-free reaction on the robotic platform 
The insect cell-free reaction consists of mRNA, insect cell-free extract and the 
translation premix. Prior to the robotic implementation, stability experiments regarding 
the insect cell-free extract, mRNA, translation premix and the mixing conditions were 
performed. The expression performance of the translation premix did not change after 
incubating the pipetted substances at 9°C for 18 hours. This is a pre-requisite for 
pipetting 566 wells, each including different premix substance concentrations. 
Therefore the pipetting order started with the translation premix (Figure 2). The 
stability tests for the mRNA in the transcription buffer showed 100% translational 
activity after the incubation at 9°C for 40 min (Figure 3 A). This time range is enough 
for pipetting mRNA into each of the 566 wells before the incubation. By comparing the 
absorption values of the transcription mixture before and after the transcription 
process, an accumulation of mRNA is measurable with absorption spectroscopy 
(Figure 3 B). Additionally, the quotient of A260/A280 between 1.8 and 2.0 is a 
measure for mRNA purity; the value of 1.87 for the finished transcription reaction 
confirmed insignificant protein contamination. The crude insect cell extract lost 40% of 
its expression activity after 40 minutes incubation at 9°C. Furthermore, by excessive 
mixing or using a vortex mixer to mix the extract after thawing, its expression activity 
declined to less than 40% (Figure 3 C). Therefore gentle handling, gentle mixing and 
rapid processing after thawing is critical to maintain 100% expression activity. Hence, 
the insect cell extract was added to the cell-free reaction by multichannel dispension 
right before the incubation start. Since this is a time dependent step and the robotic 
configuration did not allow a simultaneous pipetting of the desired volume range with 
eight tips, multichannel dispersion was performed by hand. The last mixing step 
before the incubation is also very important, especially when keeping the fragile insect 
cell-free extract in mind. Surprisingly, it turned out, that the insect cell-free translation 
activity is not influenced by the mixing method, and the expression reproducibility 
increased with an excessive mixing step by a vortex mixer (Figure 3 D).  
For the determination of an overall reproducibility using the robotic workstation, 18 
identical insect cell-free reactions were set up. The pipetting of the translation premix 
and the mRNA on the liquid handling station and the cell extract addition by hand, 
using a multichannel pipet, resulted in a coefficient of variation (CV) of 2.9% showing 
the reproducibility of the implementation.  
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Figure 3:  
a) Stability tests of mRNA prior to the implementation of insect cell-free expression on the 
robotic system. The influence of mRNA incubation at 9°C for three different time ranges 
(0 min, 20 min and 40 min) on the protein expression yield was tested. All samples were 
translated as described in the methods section. 
b) Determination of spectroscopic absorbance [AU] of the mRNA before and after the 
transcription process to show mRNA accumulation. 
c) Influence of cell extract mixing conditions (gentle, excessively, with a vortex mixer) on the 
expression result before the addition of mRNA and translation premix.  
d) Influence of mixing conditions (without, gentle, excessively, with a vortex mixer) on the 
expression result after the addition of mRNA and insect cell extract to the translation premix. 
 
3.2 Model-based characterization of insect cell-free reaction 
After the reproducible implementation of the insect cell-free expression on the robotic 
platform, all insect cell-free expression experiments were conducted for both insect 
cell types, Sf9 and High Five™. The measured luminescence values were calibrated 
and the set of 566 experiments was analyzed (Figure 2).  
A quadratic model function with interaction terms was fitted to the data (see section 
2.8). The coefficients of determination (R²), describing the ratio of the model-explained 
variance in data compared to the unexplained variance, hence representing a quality 
measure for the model between 0 and 1, were 0.89 for Sf9 and 0.83 for High Five™, 
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respectively. Also PRESS (Prediction Sum of Squares) was calculated for both 
regression models by crossvalidation, where observations are removed and the left 
out values are predicted based on a refitted model. The values of 0.87 (Sf9) and 0.79 
(High Five™) indicate that the model is predictive and not over-parameterized. All 
characteristic values for model building and validation, including the root mean square 
error (RMSE), the root of the sum of squared distances between real measurements 
and the model-based predicted values are also given in Table 2.  
 
Table 2: Summary of the model-based analysis: 
Summary Table Sf9 High Five™ 
R
2 
0.892 0.828 
PRESS R
2 
(Q
2
) 0.871 0.787 
RMSE  
(root mean square error) 
8.753x10
-5
 5.09x10
-5
 
Validation RMSE 2.288x10
-4
 8.639x10
-4
 
 
The linear influences of the different translation premix components present in the 
model equation (Figure 4 A and B) and the twenty most significant influencing 
interactions on the protein yield of Sf9 and High Five™ (Figure 4 C and D) are shown 
as scaled and centered coefficient plots. The bar size represents the influence of a 
substance on the expression yield, and can be positively or negatively correlated. The 
95% confidence intervals were calculated and a t-test with α = 5% was conducted. 
With this test, the significance of the coefficients can be determined. The coefficients 
HEPES-KOH and AA showed no linear influence in both cell systems, whereas the 
linear effects of RNAse Inhibitor and GTP were not significant in the High Five™ 
system. Therefore, these terms were not included into the respective model equation. 
For both cell systems, positive linear effects on the expression performance were 
determined for EGTA, CK, tRNA and ATP whereas negative effects on the yield were 
detected for CP, MgO(Ac)2, KOAc and DTT. The two substances additionally affecting 
the protein yield in the Sf9 system linearly are acting differently; GTP influences the 
yield negatively whereas an increase of RNAse Inhibitor increases the yield. The 
coefficient plots of the linear effects are very similar for Sf9 and High Five™, 
displaying identical effects for all substances; only the strengths of the effects are 
slightly different (compare Figure 4 A and B). In both systems, CP and EGTA are 
showing the highest influence on the expression yield of all translation premix 
substances. Regarding the twenty most significant influencing interaction effects on 
the expression yield, CP shows the highest quadratic effect on both cell systems 
(Figure 4 C and D). On the Sf9 system, the interaction of CP and EGTA as well as CP 
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and KOAc is remarkably strong. The yield of protein from High Five™ is mostly 
affected by the quadratic effects of EGTA and the influence of the interaction between 
CP and EGTA. Furthermore, both systems are significantly affected by the 
interactions of CP and EGTA with other translation premix components.  
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Figure 4: Scaled and centered coefficient plots with confidence intervals (95%) for Sf9 (A: linear 
influences, C: nonlinear influences) and High Five™ (B: linear influences, D: nonlinear influences) 
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Figures 5 A (Sf9) and 5 B (High Five™) display the sensitivity of the expression yields 
to the relevant translation premix substances including confidence intervals of 95%. 
The general curvature of the sensitivity plots corresponds to the magnitude of effect 
already explained in Figure 4, but they offer some more information on optimal 
parameter settings. In detail, the highest expression yield with the Sf9 cell-free system 
can be reached using a DTT concentration of 2.5 mM and a MgO(Ac)2 concentration 
of 1.5 mM. Whereas in the High Five™ cell-free expression an ATP concentration of 
1 mM, a KOAc concentration of 50 mM and an EGTA concentration of 6 mM provide 
the highest protein yield. For KOAc in the Sf9 system the lowest applied concentration 
showed a maximum in expression yield. Therefore, increasing the KOAc 
concentration would decrease the yield. Similarly, an increasing MgO(Ac)2 or DTT 
concentration influences the expression result of the High Five™ system negatively 
(Figure 5 B). Therefore, the respective minimum concentrations were optimal. CK, 
tRNA, EGTA and ATP concentrations in the SF9 system as well as CK and tRNA 
concentrations in the High Five™ system show a maximum, therefore the highest 
expression yield is reachable with these substances highest concentrations applied in 
this study (Figure 5 A and B). As an exception to the before mentioned results, the 
cell-free expression system is very sensitive regarding the component CP. Its 
influence on the expression yield shows an identical minimal turnover (~70 mM CP) in 
both here applied insect cell extracts. Therefore, the model-based analysis suggests 
that a lower or a higher substance concentration of CP would both lead to higher 
protein expression yields. Overall, the translation premix substance concentration 
influences on the expression yield are very similar for Sf9 and High Five™. Compared 
to previous studies, the main differences between the results of the here applied 
model-based approaches and Ezure et al. [23] is the detected need for a higher EGTA 
concentration (~7 mM compared to 0.25 mM [23] for the HighFive™ extract) and a 
lower Mg
2+
 concentration (1 mM compared to 2 mM for the HighFive™ extract) for 
optimal yield. Furthermore, the optimum of CP was described by Ezure et al. [23] at a 
concentration of 20 mM, whereas the model-based analysis suggests lower or higher 
concentrations for a higher expression yield. Thus, the presented approach confirms 
most of the linear effects determined by Ezure et al. [23] as well as the high sensitivity 
of the system to CP, but the presented methodology provides additional information 
on factor interactions and is based on highly parallelized and automated HTS 
experiments reducing the consumption of resources and the experimental effort. 
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Figure 5: 
 
A) Concentration effects on the Sf9 insect cell-free protein synthesis of the translation premix 
parameters (ATP, GTP, DTT, tRNA, KOAc, MgO(Ac)2, CP, CK, EGTA, and RNAse Inhibitor). The 
impact of every substance concentration on the Firefly Luciferase yield [mg/ml] of the model-
based results is displayed with the blue line. The dotted blue lines are confidence intervals 
(95%). 
48 Publications and Manuscripts 
B) Concentration effects on the High Five™ insect cell-free protein synthesis of the translation 
premix parameters (ATP, DTT, tRNA, KOAc, MgO(Ac)2, CP, CK and EGTA). The impact of 
every substance concentration on the Firefly Luciferase yield [mg/ml] of the model-based 
results is displayed with the blue line. The dotted blue lines are confidence intervals (95%). 
 
4 Discussion 
In this study, insect cell-free expression on a robotic platform was successfully 
implemented. This included stability tests of the translation premix, the mRNA and the 
insect cell-free extract prior to the expression process. Additionally, mixing conditions 
for the insect cell-free extract and the translation reaction immediately prior to 
incubation were tested. These results indicated that the insect cell-free extract must 
be handled carefully and allowed for the development of a stable and reproducible 
HTS process. Consequently, a model-based characterization of the effects of reaction 
substance composition to the yield of an insect cell-free system was conducted. A 
response surface model was established based on DoE-planned experimental data 
and was used for the characterization of the effects of all twelve translation premix 
substances on the expression yield. A comparison between the model-based results 
to a manual one-factor-at-a-time insect cell-free expression characterization by Ezure 
et al. [23] showed that in general both approaches lead to similar results on the single 
substance effects. Whereas Ezure et al. [23] used purified mRNA templates, in this 
study the transcription mixture was directly pipetted into the translation reaction. 
Through this step a small amount of Mg
2+
 is additionally added to the translation 
premix. This is probably the reason for the higher EGTA and lower Mg
2+
 concentration 
necessary for optimal yield in this study. Divalent Mg
2+
 ions are essential for many 
biological reactions and one of the most influential factors in cell-free reaction mixture 
[97]. Their importance and their interaction with EGTA was shown and characterized 
in the presented model-based analysis.  
It has been previously shown, that extremely low CP concentrations reduce the 
protein expression yield in cell-free expression systems dramatically and that 
significantly higher concentrations inhibit the complete reaction [98], due to the 
accumulation of inorganic phosphate [74]. Ezure et al. [23] suggested in their 
publication an optimum of 20 mM CP which is quite opposite to the results of the 
model-based analysis investigated here. A substantiated explanation of this difference 
is however currently not at hand. However, both approaches show, that the insect cell-
free expression system responds very sensitively to a CP concentration change 
(Figure 4 and 5).  
In vitro protein expression translation premixes consist of three main substance parts, 
the energy regenerating system, different metal ions and essential substances for the 
expression process. With the model-based analysis in this study the influences of the 
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different premix components and their concentrations on the luciferase expression 
yield of two different cell extracts (Sf9 and High Five™) were observed and 
characterized. Thus, an improvement of the methodology of investigating cell-free 
expression by visualizing component interactions and influences on the expression 
yield was provided. Furthermore, this new approach yields comparable results to 
previous characterizations of the insect cell-free reactions [23,98] but outperforms 
them by the efficient transfer to high-throughput experimentation and the possibility to 
determine interaction effects of premix substances. All in all, we have established a 
high-throughput tool for further investigations and optimization experiments of cell-free 
extracts in different cell types, regarding reaction characterization and the 
corresponding enhancement of protein yield. 
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Abstract 
The autoantigen U1-68/70 K is the dominant diagnostic marker in Mixed Connective 
Tissue Disease (MCTD) that until recently could not be expressed in its full-length 
form [Northemann et al., 1995]. Using cell-free expression screening, we successfully 
produced the snRNP protein U1-68/70 K in a soluble full-length form in 
Escherichia coli cells. The protein length and identity was determined by Western Blot 
and MS/MS analysis. Additionally, its reactivity in the autoimmune diagnostic was 
confirmed. Establishment of a cell-free expression system for this protein was 
important for further elucidation of protein expression properties such as the cDNA 
construct, expression temperature and folding properties; these parameters can now 
be determined in a fast and resource-conserving manner. 
 
  
52 Publications and Manuscripts 
Introduction 
The U1-68/70 K protein, a component of the nuclear spliceosomal U1-snRNP particle 
[99], is a major autoantigen in autoimmune diseases such as Mixed Connective 
Tissue Disease (MCTD) or Systemic Lupus Erythematodes (SLE; [100,101]). 
Biotechnological production of U1-68/70 K as a diagnostic autoantigen for detection of 
autoantibodies in patient sera has so far been difficult, most likely due to the sequence 
and structural peculiarities of the protein. 
U1-68/70 K (total length 437 amino acids) has a long repetitive sequence between 
amino acids 231 and 393 with a very large proportion of basic (41 % arginine-
residues) and acidic (30 %) amino acids [102,103]. Crystal structure analysis of the 
U1-snRNP particle [104] reveals that the first 60 amino acids of U1-68/70 K wrap 
around the common heptameric Sm snRNP-core in an unusual extended 
conformation devoid of regular secondary structure. A helical section (amino acids 61 
- 89) and a RNA binding RRM-domain (amino acids 100 - 180) contact the U1-RNA 
component of the U1-snRNP. The crystal structure analysis [104] however does not 
include the C-terminal half of U1-68/70 K, which is thought to be unstructured and to 
provide binding sites for numerous constitutive and alternative splicing factors 
[105,106] and possibly for RNA in protamine-like fashion [102]; these activities may be 
regulated by serine phosphorylation [107]. 
Screening of a large panel of MCTD patient sera identified four major continuous 
domains within the human U1-68/70 K as autoantibody targets, referred to as regions 
A’, B’, C’ and [108–111]. Recombinant E. coli-based production of U1-68/70 K has 
been possible only for fragments with the antigenic epitopes, but not for the full-length 
U1-68/70 K protein [112,113]. Northemann et al. [6] detected an inhibitory element 
within the full-length sequence of U1-68/70 K (sequence X) and proposed that this 
element interferes with translation. Expression of a protein containing the inhibitory 
sequence X could inhibit trans-actively the synthesis of other E. coli proteins indicating 
that full-length expression of U1-68/70 K is impossible [6]. Experiments with various 
deletions of the inhibitory sequence have shown that the number of deletions 
correlates with the expression level of the truncated U1-68/70 K protein [TS, 
unpublished data]. Interestingly, the inhibitory element corresponds to part of the 
charged arginine-rich unstructured region of U1-68/70 K.  
To shed some light into this, several expression strategies have been evaluated so far 
[6]. Truncated forms of U1-68/70 K have been produced in a cell-free wheat germ 
system for protein-protein interaction studies [114]. In recent years, in vitro translation 
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has become an important tool for rapid and cost reduced screening of different protein 
expression conditions. Combining in vitro expression with high-throughput parameter 
optimization [2] followed by transfer to cell-based expression is a valid approach for 
folded and soluble difficult-to-express proteins [115–117]. Variables such as the 
comparison of eukaryotic or prokaryotic systems, requirements of auxiliary factors 
(e.g. the addition of chaperones, detergents or cofactors) or protein- and process-
specific ones (e.g. temperature, time) can be estimated [118]. However, the full-length 
expression of the U1-68/70 K autoantigen has not been reported in literature so far.  
In this study, we evaluated the potential of an E. coli cell-free translation system for 
producing soluble full-length human U1-68/70 K protein. Furthermore it was elucidated 
if data from cell-free expression provide useful informations regarding optimizing cell-
based expression strategies. Several parameters, which were determined via the 
E. coli in vitro expression system, could be successfully transferred to a cell-based 
approach. The resulting expression strategy allows now for the first time expression of 
a soluble, full-length and immunologically active U1-68/70 K autoantigen in E. coli 
cells. This result enables further characterization of the human U1-68/70 K full-length 
protein in either structural or functional studies.  
 
Material and Methods 
DNA template generation: cloning and codon optimization. Work was carried out 
with the alternatively spliced shorter U1-68 K isoform of human U1-68/70 K (UniProt 
ID: P08621 – isoform 2). Full-length as well as the truncated (lacking the 66 AA 
inhibitory sequence X – Figure 1) cDNA constructs were cloned into different vector 
systems:  
 pET24d (Merck Millipore, Germany) for E. coli cell-free and cell-based 
expression. 
 pCDF-Duet-1 (Merck Millipore, Germany) for co-expression with pET24d-
based chaperone constructs in E. coli cells. 
All vectors included C-terminal hexahistidine tags, whereas expression vectors of the 
original human cDNA sequence additionally included N-terminal hexahistidine tags 
(see supporting information Figure A1). All constructs were verified by resequencing 
(Solvias AG, Switzerland). In addition to constructs with the original human cDNA 
sequence, full-length and truncated U1-68/70 K cDNAs were codon-optimized for 
E. coli expression. Web-based bioinformatic tools were: codon usage 
(http://www.entelechon.com); GC content (http://www.bioinformatics.org); RNA 
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secondary structure (www.genebee.msu.su). Gene synthesis was done by Entelechon 
GmbH (Germany). 
Coding regions for the chaperones dnaK, dnaJ and grpE were PCR-amplified from 
E. coli BL21 and cloned into pET24d. For chaperone co-expression, ribosome binding 
site/chaperone cassettes were combined in a single pET24d construct, with 
expression of a polycistronic mRNA driven from a single T7 promoter. 
 
     Inhibitory sequence X [6]  
                           250        260        270        280        290 
U1-68/70 K           KERERRRSRS RDRRRRSRSR DKEERRRSRE RSKDKDRDRK RRSSRSRERA 
U1-68/70 K_truncated KERERRRSRS RDRRRRSRSR ---------- ---------- ---------- 
                    ********** **********                                  
                           300        310        320        330        340 
U1-68/70 K           RRERERKEEL RGGGGDMAEP SEAGDAPPDD GPPGELGPDG PDGPEEKGRD 
U1-68/70 K_truncated ---------- ---------- ---------- ----- GPDG PDGPEEKGRD 
                                                           **** ********** 
Figure 1: Amino acid sequence comparison of the full-length and truncated U1-68/70 K at the 
inhibitory sequence X region. 
 
Preparation of bacterial cell-free extract. For cell-free expression the RNaseE-
mutant E. coli BL21 Star
TM
 (DE3) strain (Life Technologies GmbH, Germany) was 
transformed with pRARE2 (isolated from E. coli Rosetta2, Merck Millipore, Germany). 
Bacterial cell-free extract was prepared according to Kim et al. [54] using the 
simplified procedure (S12) including slight modifications.  
 
In vitro expression method. E. coli cell-free expression was carried out either in 
50 µl (analytic) or 500 µl (preparative) reaction volumes. The cell-free reaction mixture 
(Kim et al. [73] with slight modifications) was adapted to the S12 extract. To the cell-
free reactions 6 % of DnaK supplement (5 Prime, Germany) was added. Expression 
temperature was set to a value between 15 – 37°C and reactions were incubated 
overnight (~12 – 14 h) in a thermo mixer at 300 rpm. Negative controls excluded 
plasmid DNA and were performed for all cell-free expression methods; control 
background was analyzed in parallel to the product-containing reactions. 
 
In vivo expression method. BL21Star
TM
(DE3) bacteria transformed with the 
respective cDNA expression constructs were grown as overnight pre-cultures in MDG 
media at 37°C. Expression cultures were grown with PepYMD-505 (Studier's ZYM-
505 medium with added aspartic acid and NZ-Amine replaced by peptone; [119]). At a 
bacterial density of OD600nm = 0.6, cultures were induced by addition of 1 mM IPTG. 
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For protein expression, bacterial cultures were incubated overnight at 25°C at 300 rpm 
in an incubation shaker (Infors, Switzerland).  
 
Protein analysis. Overnight E. coli cell-free reactions were centrifuged (16 000 x g; 
5 min), the pellet was washed once with phosphate buffered saline (PBS) (1.5 M 
NaCl, 37 mM NaH2PO4 and 163 mM Na2HPO4) and solubilized in 1 % sodium dodecyl 
sulfate (SDS). E. coli cell lysates from E. coli cell-based expression cultures were 
prepared by lysozyme treatment, addition of Triton X-100 to 1 % final concentration 
and freeze-thaw steps. Lysates were centrifuged (16 000 x g; 5 min) for fractionation 
of soluble vs. insoluble components. Identical volumes of reducing SDS sample buffer 
were added to cell-free and cell-based samples. All samples were denatured for 5 min 
at 95°C and analyzed by SDS-PAGE using 6 % - 20 % gradient gels. SDS gels were 
either stained with Coomassie Brilliant Blue R250 or used for Western Blot analysis by 
transferring the proteins onto PVDF membranes (Pall GmbH, Germany).  
For sensitive product detection in cell-free reactions, newly-synthesized proteins were 
fluorescently labeled by addition of 1 µl FluoroTect
TM
 GreenLys label (Promega 
GmbH, Germany) to a 50 µl in vitro reaction. Labeled cell-free reactions were diluted 
1:4 in reducing SDS sample buffer, denatured for 2 minutes at 70°C and analyzed by 
SDS-PAGE. SDS gels were scanned for fluorescence detection of labeled proteins in 
an Ettan DIGE Imager (GE Healthcare, Germany) using the Cy2 channel. 
For immunological detection of His-tagged proteins on Western Blots, anti-
pentahistidine antibody (Qiagen GmbH, Germany) followed by anti-mouse IgG 
antibody-alkaline phosphatase conjugate (Jackson ImmunoResearch, USA) was 
used. The autoantigenic immunological activity of U1-68/70 K products was verified on 
Western Blot with an autoantibody-positive patient serum and a secondary goat anti-
human IgG antibody-AP (Jackson ImmunoResearch, USA). Primary antibodies were 
diluted 1:1000, secondary antibodies 1:5000 in 1 % casein / TBS (10 mM Tris, 
150 mM NaCl, pH 7.5). The colorimetric detection of AP conjugates was 
accomplished with BCIP/NBT purple one-component AP membrane substrate solution 
(Surmodics - BioFX, USA). 
 
Protein purification for MS/MS analysis. U1-68/70 K was purified with 
Ni-Sepharose High Performance spin columns according to the manufacturer’s 
protocol (GE Healthcare, Germany). Protein samples were adjusted to 6 M guanidine-
HCl, 20 mM HEPES pH 7.9 and bound to the column overnight at 4°C. After washing 
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steps with 6 M urea, 20 mM HEPES pH 7.9, the columns were eluted with 100 mM, 
250 mM and 500 mM imidazol in 6 M urea, 20 mM HEPES pH 7.9, respectively. 
 
Protein analysis with matrix-assisted laser desorption/ionization-time-of-
flight (MS/MS). SDS-PAGE separation was done as described above. Coomassie 
stained U1-68/70 K protein gel bands were excised and destained by several wash 
cycles with 50 % acetonitrile in 25 mM ammonium bicarbonate and 25 mM ammonium 
bicarbonate with 10 minutes in each solution. Gel pieces were dehydrated by washing 
with 100 % acetonitrile. For trypsin digestion, the dried gel pieces were soaked in 
20 µl trypsin (Promega GmbH, Germany) solution (25 ng/µl in 10 mM ammonium 
bicarbonate), covered with 50 µl ammonium bicarbonate (25 mM) and incubated 
overnight at 37°C on a thermo mixer. For MS/MS analysis 0.5 µl of the respective 
peptide sample was mixed with 0.5 µl MALDI-matrix (0.1 % trifluoroacetic acid, 50 % 
acetonitrile, and 10 mg/ml 4-OH-cinnamic acid) and spotted on a stainless steel 
MALDI target. Analyses were performed using a MALDI-time-of-flight (TOF)-MS/MS 
(4800 MALDI-ToF/ToF mass spectrometer; Data Explorer Software 4.0, Applied 
Biosystems, Framingham, MA). Generated peak lists were calibrated against a 
peptide standard mixture (des-Arg-Bradykinin m/z: 904.4681; Angiotensin I m/z: 
1,296.6853; Glu-Fibrinopeptide B m/z: 1,570.6774; adrenocorticotropic hormone clip 
1-17 m/z: 2,093.0867; adrenocorticotropic hormone clip 18–39 m/z: 2,465.1989). 
Significant peptides were selected for further MS/MS runs to determine the amino acid 
sequences. 
 
Results 
Initial experiments for cell-free synthesis were performed with U1-68/70 K expression 
constructs (full-length and truncated, Figure 1) derived from the original human cDNA 
sequence. Expression analysis show a single band of newly synthesized protein with 
apparent molecular weight of 27 kDa for the full-length and the truncated U1-68/70 K 
construct (Figure 2a), suggesting that premature termination of protein synthesis 
occurs before the inhibitory region (here the two constructs diverge). A fragment of the 
first 225 residues of U1-68/70 K up to the arginine repeats region would have a 
calculated MW of 26.2 kDa. Unfortunately, in SDS gels interpretation of an exact 
termination site is complicated because of the aberrant electrophoretic mobility of U1-
68/70 K which migrates at around 70 kDa despite an calculated MW of 52 kDa [103]. 
Analysis of the short synthesis product by mass spectroscopy identified several 
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peptides covering a total of 63 amino acids between position 2 and 155 of U1-68/70 K, 
thus confirming the assignment as an N-terminal U1-68/70 K fragment. Premature 
termination of cell-free U1-68/70 K synthesis could have different explanations: for 
instance, limitation of arginine-loaded tRNAs in the E. coli cell-free system could 
complicate synthesis of the arginine repeat region, or the twin pair of rare AGG-AGG 
arginine codons at positions 172-173 causes translational problems (pausing, frame 
shifting, premature degradation) known from previous in vivo expression work [120–
122]. At this stage, optimization work was started to firstly increase and verify the 
protein synthesis capacity of the E. coli cell-free system, and secondly optimize the 
U1-68/70 K plasmid template by a gene synthesis approach. 
Therefore, the first change to the cell-free system was the application of the ‘Dual 
Energy’ system [73] to S12 bacterial extracts [25]: the ATP in long-term synthesis 
reactions is regenerated from creatine phosphate via creatine kinase as well as from 
glucose metabolism, which is enhanced through NAD
+
 and coenzyme A addition. 
Furthermore, an increase of potassium glutamate from 0.09 M [73] to 0.13 M 
stabilized the consumption of Mg
2+
. Glutamate is able to bind Mg
2+
and can therefore 
serve as a sort of buffer [123]. While all these optimization strategies could help to 
increase the protein synthesis yield, they did not lead to detectable amounts of full-
length U1-68/70 K protein (data not shown).  
The gene synthesis approach included both full-length and truncated U1-68/70 K 
constructs which were codon optimized by exchanging all "rare" codons (ATA, CTA, 
CCC, CGA, CGG, AGA and AGG) with synonymous codons, which are preferred in 
"Class II" E. coli genes with high and continuous expression during exponential growth 
[124]. Within the U1-68/70 K protein constraints only slight reductions of GC content 
(fl: 63 %  60 %; tr: 61 %  59 %) and free energy content in stem loop structures (fl: 
-25.4 kcal/mol  -21.9 kcal/mol; tr: -24.2 kcal/mol  -22.9 kcal/mol) could be 
incorporated into the design. 
However, no completed synthesis products were observed when expression 
constructs with codon-optimized synthetic U1-68/70 K genes were tested in E. coli 
cell-free reactions. Several termination products with apparent molecular weights up 
to 37 kDa were identified with similar patterns in full-length vs. truncated U1-68/70 K 
constructs (Figure 2b). As the proteins in Figure 2a and b were produced including 
FluoroTect
TM
 GreenLys label (Promega GmbH, Germany), the excess lysine-loaded 
and labelled tRNA are visible in the two figures (band sizes smaller than 25 kDa). The 
increase of size and band number relative to initial observations of primary U1-
68/70 K constructs indicates that the protein synthesis block of the natural cDNA 
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sequence is cured by codon optimization. Actually a synthesis block at a rare codon 
cluster, such as position 172-173 seems to limit the in vitro synthesis from a natural 
U1-68/70 K cDNA sequence. The increased size of the termination products from the 
synthetic gene constructs places the new synthesis block in the first arginine repeat 
region in front of the inhibitory sequence. 
Since chaperones are known to stabilize chain elongation at the ribosome during 
protein expression [125], an optimization strategy using the addition of DnaK, DnaJ 
and GrpE in cell-free expression experiments further demonstrated the advantage of 
in vitro expression as an open system. This was an essential improvement for 
obtaining the U1-68/70 K protein, which can be demonstrated by the now existing 
difference between the truncated (50 kDa) and the full-length form (68 kDa) (Figure 
2c). Both U1-68/70 K protein lengths could be expressed partly soluble, whereas the 
truncated protein showed a higher content of abortion products (Figure 2c). 
However, at the conventional in vitro expression temperature of 37°C [68] only 
truncated U1-68/70 K was expressed (data not shown). Therefore, the following 
optimization step addressed the temperature dependency of U1-68/70 K protein 
production in the cell-free expression system. By decreasing the temperature, both 
full-length and truncated proteins could be expressed with the highest amount of 
protein at 25°C overnight (Figure 2c). Below this optimum, the truncated and the full-
length U1-68/70 K were visible to a lower extent at 20°C (in SDS gels using 
FluoroTect
TM
 GreenLys labels); no expression could be detected at 15°C. Protein 
expression at lower temperatures limits aggregation [126] whereas chaperone activity 
increases with higher temperatures up to their optimum at 30°C [127].  
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a)   b)     c) 
 
Figure 2: Expression analysis of U1-68/70 K (full-length and truncated) in the E. coli cell-free system 
(M=marker; N=negative control; fl=full-length; tr=truncated; t=total cell-free extract; s=supernatant; 
p=pellet fraction) 
a) Detection of FluoroTect
TM
 GreenLys labeled U1-68/70 K expressed with the original human 
cDNA sequence (proteins are indicated) via SDS-PAGE using a Cy2-filter. Excess lysine-load 
and labelled tRNA of FluoroTect
TM
 GreenLys label (Promega GmbH, Germany) are also visible 
(band sizes smaller than 25 kDa). 
b) Detection of FluoroTect
TM
 GreenLys labeled U1-68/70 K expressed with the  
codon optimized cDNA sequence (proteins are indicated) via SDS-PAGE using a Cy2-filter. 
Excess lysine-load and labelled tRNA of FluoroTect
TM
 GreenLys label (Promega GmbH, 
Germany) are also visible (band sizes smaller than 25 kDa). 
c) Western Blot analysis (using anti-pentahistidine antibody (Qiagen GmbH, Germany) of codon 
optimized U1-68/70 K including DnaK/DnaJ and GroE supplement 
 
To demonstrate adaptability of the optimization results from the cell-free expression to 
a cell-based approach, the important parameters were transferred to an E. coli cell-
based system. Whereas expression temperature (25°C) and duration (overnight) 
could easily be adopted, the co-expression of the chaperone system and U1-68/70 K 
protein required additional plasmid construction. For both proteins the overall 
expression yields of the natural cDNA and the codon optimized cDNA construct of U1-
68/70 K co-expressing the three chaperones did not increase significantly (Figure 3a 
and b). However, the solubility of both truncated and full-length U1-68/70 K proteins 
shifted to 100 % with the codon-optimized cDNA and chaperone coexpression. The 
overexpressed chaperones DnaK (70 kDa), DnaJ (42 kDa) and GrpE (20 kDa) could 
be detected as prominent bands (Figure 3b). 
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a)      b) 
 
      --------------------  -----------------          --------------------  ------------------   
             natural cDNA        codon opt. cDNA                natural cDNA         codon opt. cDNA     
                                                   +                                                                           +                  
                                          chaperone addition                                            chaperone addition 
 
Figure 3: Expression analysis of U1-68/70 K in E. coli BL21 Star
TM
 (DE3) before and after the 
application of the optimization strategies. 
(M=marker; NI= not induced control reaction; t=total cell extract; s=supernatant; p=pellet fraction) 
a) Full-length U1-68/70 K protein expression of the natural cDNA and the codon optimized cDNA, 
coexpressed with the chaperone system; proteins are indicated (dotted line). Protein 
detection was accomplished by Western Blot analysis using anti-pentahistidine antibody 
(Qiagen GmbH, Germany). 
b) Truncated U1-68/70 K protein expression of the natural cDNA and codon optimized cDNA, 
coexpressed with the chaperone system; proteins are indicated (dotted line). Protein 
detection was accomplished on a SDS-PAGE with Coomassie staining. 
 
As mentioned previously, U1-68/70 K shows an aberrant performance in gel 
electrophoresis, hence a mass spectrometry analysis was undertaken to prove the 
full-length character of the soluble protein. The overall coverage of the U1-68/70 K 
full-length protein by peptide mass fingerprint analysis was 28 %. The detected 
peptide sequences, masses and corresponding amino acid sequences are listed in 
supporting information (Figure A1). Using tandem mass spectrometry (MS/MS) the 
corresponding amino acid sequences of the four main peptides were determined. This 
observation of one peptide covering the end of the inhibitory sequence X into the C-
terminal part proves that full-length U1-68/70 K was obtained (supporting information 
Figure A2).  
The immunological activity of the U1-68/70 K full-length protein produced in E. coli 
cells was verified by an immunoblot using a U1-68/70 K specific patient serum. 
 
Discussion 
The U1-snRNP protein U1-68/70 K has been known for many years as a major 
autoantigen in MCTD and other autoimmune diseases [100,101]. To date it was not 
possible to express this protein in its full-length immunologically active form, because 
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of its inhibitory sequence X [6]. By codon usage improvements on the cDNA level and 
cell-free expression optimization, the expression of the immunoreactive full-length U1-
68/70 K protein was successful and could be proven by MS/MS analysis and 
immunoblotting. Furthermore, using this in vitro approach, expression parameters for 
this specific protein (temperature, duration and chaperone addition) could be 
transferred to an E. coli cell-based expression system. Overall, the application of the 
cell-free expression is a simple method, which reduces optimization time and reagent 
costs.  
Northemann et al. [6] concluded that the translation inhibition of the “inhibitory 
sequence X” within the full-length U1-68/70 K is characterized as being trans-active, 
suppressing protein expression under the same promoter type within one expression 
plasmid. An extension of these observations was made in this study by comparing 
E. coli cell-based chaperone coexpression experiments of full-length vs. truncated 
(lacking the inhibitory sequence X) U1-68/70 K protein: with full-length U1-68/70 K 
protein the coexpression levels of the three chaperones from their separate 
expression plasmid were partly reduced (data not shown), indicating an inhibitory 
effect of full-length protein on the translational activity of the cells.  
In contrast to Northemann et al. we already detected some expression of the full-
length U1-68/70 K in E. coli cells when using the natural cDNA sequence without 
chaperone addition. However, a number of differences to Northemann et al. can 
explain our observations of accumulating U1-68/70 K protein: the optimized 25° C 
expression temperature (instead of 37° C), use of the strong T7 promoter (instead of a 
tac promoter), and the longer expression duration (overnight vs. 5 h).  
Full-length U1-68/70 K's stringent inhibitory effect on translation was uniquely visible 
in cell-free translation, where no full-length protein was found and the detection of 
partial products was possible. After removal of a rare codon translation obstacle by 
codon optimization, a translation block remained for full-length and truncated U1-
68/70 K which was mapped to the beginning of the arginine-rich region (despite 
deletion of the "inhibitory region X" the truncated U1-68/70 K version retains part of 
the arginine-rich region). Non-specific-causes such as depletion of the arginine amino 
acid pool in the reaction can be ruled out, since a specific mechanism for the 
translation block is indicated by the defined nature of the partial product bands and the 
translation block removal in the presence of DnaK/DnaJ chaperones. In general, the 
DnaK and DnaJ chaperone system is known to be associated with 5-18% of newly-
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synthesized proteins within E. coli cells [128]. Furthermore, deletion of the DnaK gene 
in the E. coli chromosome is lethal for the cell because of massive protein aggregation 
[125]. The peptide binding specificity of DnaK has been mapped [129]: similar to other 
general chaperones of the Hsp70 family DnaK binds to exposed stretches of 
hydrophobic peptides such as found in misfolded proteins. In addition, a unique ability 
of DnaK to bind arginine and lysin-rich basic peptides has been observed [129], with 
important implications for the present study. A reasonable theory is that the 
translational block acting on nascent U1-68/70 K protein is removed by binding of 
DnaK to the arginine-rich region of U1-68/70 K. This can happen during protein 
synthesis only after the arginine-rich region begins to exit from the ribosomal tunnel 
and becomes accessible [128]. If not captured by DnaK, the arginine-rich region can 
be assumed to rebind to the surface of the ribosome, possibly to a RNA component, 
and thereby to interfere with translational activity. To our knowledge, this is a novel 
mechanism for translational inhibition of an active ribosome. 
Apart from the implications for ribosome biology and biotechnological expression 
optimization via in vitro approaches, the outcome of this study will enable further 
understanding of the spliceosomal complex including U1-68/70 K and its role in 
autoimmunity. Furthermore, it shows the importance of chaperones for protein folding 
in overexpression of heterologous proteins in E. coli. 
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Abstract 
Lyme borreliosis is the most common tick-borne disease in North America and 
Europe. A two-test approach (an ELISA followed by immunoblots) for testing current 
and past infection has been adopted in most countries. However, the heterogeneity of 
Borrelia antigens and the semiquantitative character of the immunoblot remain a 
limitation. By combining a microarray system with cell-free expression, we established 
a procedure for the expression and subsequent printing of different Borrelia antigens 
onto several multi-well microarray plate surfaces. We successfully expressed and 
partially purified eleven immunodominant antigens of Lyme borreliosis from different 
Borrelia species in a self-generated Escherichia coli cell-free system. Using sera from 
patients suffering from Lyme disease and different specific monoclonal antibodies, 
proteins could be reproducibly detected on the microarray plates. To confirm the 
diagnostic outcome of the new assay, a comparison to the same cell-based 
expressed, purified and printed Borrelia antigens was performed. In summary, this 
approach serves as a proof of principle for the identification of potential biomarkers 
and offers the possibility of multiplex protein detection for specific diseases. 
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1 Introduction 
Lyme borreliosis, caused by spirochetal bacteria from the genus Borrelia, is the most 
common tick-borne disease in North America and Europe [130]. In Germany, 
1 000 000 incident cases of this disease are registered per year (www.borreliose-
nachrichten.de, 2011). Failure to identify and treat Lyme disease early results in later 
onset of symptoms which may involve the joints, heart and central nervous system 
[130]. In Europe, five different species of Borrelia burgdorferi are considered to cause 
Lyme disease: B. burgdorferi sensu stricto, Borrelia afzelii, Borrelia garinii, 
Borrelia spielmanii and the not yet validated species Borrelia bavariensis [131]. In 
most cases, Lyme disease is diagnosed by serological confirmation after the 
appearance of a red skin rash (erythema migrans). The lack of standardization and 
poor evaluation of the sensitivity and specificity of diagnostics is caused by the broad 
heterogeneity of Borrelia strains [132]. Therefore, a two-tiered test comprising an 
initial screen using an ELISA followed by an immunoblot [133,134] is the method of 
choice. The advantages of this diagnostic approach include high sensitivity and 
specificity within the first weeks of a B. burgdorferi infection and the consistency of 
results in experienced laboratories [135]. Heterogeneity of the immunodominant 
antigens remains an issue, because a whole cell lysate immunoblot involves only one 
strain [136]. Additionally, standardization is difficult due to the differential expression of 
immunodominant proteins and the semiquantitative character of an immunoblot [135]. 
A promising alternative to the aforementioned difficulties is the use of recombinant 
antigens of B. burgdorferi sensu lato. The assays could include various antigens of 
proven diagnostic value from different strains, and they are expected to be more 
easily standardized and interpretable [132]. Until now different diagnostic Borrelia 
antigens from the strains were discovered and included in immunoassays [137–139]. 
To improve, accelerate and reduce costs of conventional diagnostic methods, protein 
microarrays came into the picture. As Ekins et al. [140] stated in their ambient analyte 
theory in the 1990s, a very small spot of macromolecules e.g. antibodies can provide 
better sensitivity than conventional immunoassays. Although DNA microarray 
technology became very important in gene expressing profiling [141–145], protein 
microarrays are more and more widely used in proteomic research [146,147]. They 
facilitate the identification and quantitation of proteins as well as their function in 
biological processes and the proteome. Furthermore, protein microarrays are 
predestined for measuring the amounts of high numbers of proteins in complex 
mixtures, as in multiplex immunoassays.  
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Traditionally, proteins for microarray applications are expressed in cell-based systems 
and subsequently purified and immobilized on the respective surface. These are 
laborious and time-consuming steps, which can be eliminated by producing different 
proteins in small amounts using cell-free expression systems [1]. Common cell-free 
expression systems are E. coli, wheat germ extract and the rabbit reticulocyte lysate 
[1]. The combination of cell-free expression and protein microarrays is to date 
accomplished by DNA printing and a subsequent protein expression on the microarray 
surface. This is currently used successfully for a range of applications, such as 
biomarker detection in cancer and autoimmune diseases, immunological studies, 
vaccine development, protein-protein interactions and toxin detection [148,149]. The 
comparability to protein microarrays is challenging, because the difference of printing 
DNA molecules instead of proteins is evident. Furthermore, the reproducibility of on-
chip expression may limit the use of this technology in commercial diagnostics. By 
printing cell-free expressed proteins on microarray surfaces, the development of 
diagnostic microarrays for production may be improved. Faster and cost-reducing 
biomarker screening and the possibility of improving the protein conditions for printing 
may be feasible. This said the question of comparability between arrays developed on 
the basis of cell-free expression and those manufactured by the large-scale 
compatible cell-based route is still an open question. 
In this study, we compared a diagnostic protein microarray that includes eleven cell-
based and purified Borrelia antigens to a new approach, using cell-free expressed and 
crudely purified HaloTag
®
 fusion Borrelia antigens. Both protein microarray 
approaches comprising the same antigens expressed using identical complementary 
DNA (cDNA) sequences, were printed on two different plate surfaces. The results of 
these investigations provide a proof of principle for the identification of potential 
biomarkers using cell-free expression and a multiplex protein microarray to expand 
the assay portfolio for the diagnosis of Lyme disease. 
 
2 Materials and methods 
2.1 Preparation of expression plasmids 
Eleven different cDNA sequences originating from different Borrelia species (Table 1) 
were synthesized (Entelechon GmbH, Germany), cloned into pET24d vectors (Merck 
Millipore, Germany) and cell-free expressed in E. coli lysate. Vectors included either a 
N-terminal hexahistidine (His)-tag or a HaloTag7 (Promega GmbH) [5] followed by a 
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His-tag. The cDNA constructs of p41 B. burgdorferi sensu stricto and p100 
B. burgdorferi sensu stricto has a C-terminal His-tag. 
 
Table: Eleven Borrelia proteins used in this investigation and their originating species. 
No. Protein Borrelia species 
Molecular 
weight [kDa] 
Molecular 
weight of 
antigen with 
HaloTag
®
 
[kDa]
a
 
ag 1 p100 
B. burgdorferi 
sensu stricto 
77 110 
ag 2 VlsE1 B. garinii 27 60 
ag 3 p41 
B. burgdorferi 
sensu stricto 
36 67 
ag 4 DbpB 
B. burgdorferi 
sensu stricto 
19 52 
ag 5 DbpA 
B. burgdorferi 
sensu stricto 
17 52 
ag 6 DbpA B. afzelii 17 50 
ag 7 BmpA 
B. burgdorferi 
sensu stricto 
36 69 
ag 8 BmpA B. afzelii 36 69 
ag 9 OspC B. spielmanii 21 54 
ag 10 OspC 
B. burgdorferi 
sensu stricto 
21 54 
ag 11 OspA B. afzelii 29 62 
a
 For comparison of the gel-based cell-free expression analysis in supporting information Figure 1. 
 
2.2 Antigens, antibodies and patient sera 
Specific cell-based produced (E. coli or baculovirus/insect cell expression system) 
Borrelia antigens (ag) were kindly provided by DIARECT AG (Freiburg im Breisgau, 
Germany). Monoclonal antibodies (mAb) and patient sera (ps) were supplied by 
Dr. med. Volker Fingerle (National Reference Center for Borrelia, Oberschleißheim, 
Germany) and ravo Diagnostika GmbH (Freiburg im Breisgau, Germany), 
respectively. Positive patient sera (ps) were from patients diagnosed with Lyme 
disease by the standard two-tier method. 
 
2.3 Preparation of bacterial cell-free extract 
For cell-free expression the RNaseE-mutant E. coli BL21 Star™ (DE3) strain (Life 
Technologies GmbH, Germany) was transformed with pRARE2 (isolated from E. coli 
Rosetta2, Merck Millipore, Germany). Bacterial cell-free extract preparation was 
conducted according to Kim et al. [54] employing the simplified procedure (S12). 
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2.4 In vitro protein expression and purification of antigens 
E. coli cell-free expression was carried out in 500 µl reaction volume. The composition 
of the cell-free reaction (Kim et al. [73]) was modified slightly to adapt the reaction 
mixture to the S12 extract. Expression temperature was set to 30°C and reactions 
were incubated for 6 h in a thermo mixer at 300 rpm.  
The in vitro expression supernatants (100 x g; 5 min) were purified with spin columns 
containing Nickel Chelating Sepharose Fast Flow (Ni-CS) (GE Healthcare, Germany). 
For this, supernatants were concentrated with Vivaspin columns (Sartorius, Germany). 
Protein samples were adjusted to 20 mM HEPES, 500 mM sodium chloride (NaCl), 
20 mM imidazol, 1% Triton X-100, pH 8.0 and bound to the columns over night at 4°C. 
After washing steps with 20 mM HEPES, 20 mM imidazol, pH 8.0 the columns were 
eluted stepwise with an increasing Imidazol concentration up to 500 mM in 20 mM 
HEPES, pH 8.0. 
 
2.5 Protein analysis of antigens 
To determine the binding of the HaloTag
®
 to its ligand, unpurified and IMAC purified 
cell-free expressed fusion antigens (ag) were analyzed via SDS-PAGE. A negative 
control reaction including the HaloTag
®
 protein without a fusion partner was analyzed 
in parallel. After the expression, the cell-free cultures were centrifuged (100 x g; 5 min) 
and equal volumes of in vitro reaction supernatant and previously purified fusion 
protein solution (15 µl) were each incubated with 3 µl of fluorescently labeled 
HaloTag
®
 TMR Ligand at 37°C for 15 min. Equal volumes (30 µl) of reducing SDS 
sample buffer were added and samples were denatured for 5 min at 95°C and 
analyzed by 6–20% gradient SDS-PAGE. Gels were scanned for fluorescence 
detection of the HaloTag
®
 fusion antigens specifically bound to the HaloTag
®
 TMR 
Ligand in an Ettan DIGE Imager (GE Healthcare, Germany) using the Cy2 filter. 
 
2.6 Microarray performance 
For microarray printing two plate formats were used. MaxiSorp™ 96 strip well plates 
(Nunc™, Thermo Scientific) were used for total protein binding and mainly for 
antigens expressed in cells, while HaloLink™ 96 strip well plates (Promega GmbH, 
Germany) were used for a specific link of the cell-free expressed antigens containing 
a HaloTag
®. A scheme of the HaloLink™ system is given in Figure 1A. Prior to the 
printing process, samples were adjusted to carbonate buffer (pH 9.0) by buffer 
exchange using Zeba Spin Desalting Columns 7K MWCO (Thermo Scientific) 
according to the manufacturer’s protocol. Each strip of the HaloLink™ 96 strip well 
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plates and MaxiSorp™ 96 strip well plates was fixed in an adapter for the printing 
process with a contact printer (OmniGrid 100, GeneMachines, USA) using four pins. 
Seven replicates of each Borrelia antigen (Figure 1B) were printed on the two different 
plate type surfaces (HaloLink™ and MaxiSorp™). 
 
 
 
Figure 1: (A) Principle of HaloTag
®
 binding to a HaloLink™ surface. (B) Antigen matrices A, B and C 
(am-A: unpurified cell-free expressed Borrelia proteins; am-B: purified cell-free expressed Borrelia 
proteins; am-C: purified cell-based expressed Borrelia proteins) as applied in the multiplex protein 
microarrays. Seven replicate spots of Borrelia antigens were printed on two different plate type 
surfaces (HaloLink™ and MaxiSorp™). 
 
2.7 Antigen matrix for printing 
Three different antigen matrices (am) based on the different expression and 
purification approaches were used for the printing process: am-A, cell-free expressed 
HaloTag
®
 fusion antigens, unpurified; am-B, cell-free expressed and Ni-CS purified 
HaloTag
®
 fusion antigens; and am-C, cell-based expressed and purified Borrelia 
antigens (Figure 1B). 
 
2.8 On-print controls 
For evaluation and validation of the printing process, human IgG and IgM (DIANOVA 
GmbH, Hamburg, Germany) were spotted as positive controls in each microarray 
pattern. Human serum albumin (HSA) (Sigma, Germany) and crude E. coli lysate, 
which was also used for cell-free expression, were printed as negative controls.  
 
2.9 Microarray processing 
The dried microarray spots on the plate surfaces (2 h at 37°C) were blocked with 
StableGuard Choice (Surmodics, USA). To determine the diagnostic performance of 
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the distinct array types, nine different monoclonal antibodies (mAb1 – mAb9) against 
defined Borrelia antigens and sera from 14 different patients suffering from Lyme 
disease (ps1 – ps14) were used. For negative control reaction, sera from individual 
healthy blood donors were applied. The monoclonal antibodies and patient sera were 
diluted 1:100, secondary antibodies (anti-human IgG antibody-Cy5, anti-human IgM 
antibody-Cy5, anti-mouse IgG antibody-Cy5 [DIANOVA GmbH, Hamburg, Germany]) 
1:1000 in StableGuard Choice. Following incubation with the primary (60 min) and 
secondary (30 min) antibodies, the wells were washed three times with PBST (3.7 mM 
NaH2PO4, 16.3 mM Na2HPO4, 0.15 M NaCl, 0.05 % Tween20) followed by three 
washes with PBS buffer. The developed microarrays were scanned in a Fluorescence 
Array Imaging Reader “FLAIR” (Sensovation, Germany). 
2.10 Microarray data analysis 
Data normalization was performed to compensate specific effects arising from 
different plate types, different protein purities and the presence or absence of tags. 
Furthermore, microarrays in general show systematic effects due to array 
characteristics which need to be compensated. The raw fluorescence microarray data 
was normalized as shown in Equation (1), starting with a log2 transformation of the 
raw fluorescence data and followed by scale normalization including identically 
processed antigens (Beissbarth et al., Recommendations for normalization of 
microarray data. 2005 [www.science.ngfn.de]), [150]. The factor k (specifically 
k=65535) was introduced due to instrument specific data generation. 
normalized data = log2 (fluorescence data * k) – median [log2 (fluorescence data * k) 
antigens identically processed] (1) 
 
Spot reproducibility was defined to evaluate the information value of the printing 
process. It was determined by using the raw fluorescence data of the seven spot 
replicates (r1 – r7) developed by the 14 patient sera and calculating the coefficient of 
variation (CV) as outlined in Equation (2). 
CV = SD (replicates)/median (replicates)*100 [%] (2) 
 
For an overall comparison of the three different antigen matrices, the CV frequencies 
of defined percentage ranges (0-5%, 6-10%, 11-15%, 16-20% and higher than 20%) 
were compared. The lower the CV value, the higher the reproducibility of the spot 
replicates. 
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To ensure the comparability of the different antigen matrices and the different plate 
types after data normalization, an evaluation of the on-print controls was necessary. 
Therefore, an analysis of variance (ANOVA) was performed on the four different on-
print controls; two positive controls (IgG and IgM) and two negative controls (HSA and 
the cell-free E. coli extract). The null-hypothesis in the ANOVA proposed no significant 
difference between the examined observations. As a result of this evaluation, p-values 
were obtained, describing the probability of a significant difference. In general p-
values lower than a level of 0.05 describe significant effects of plates or matrices while 
p-values greater than 0.05 indicate no significant effects and therefore confirm the 
comparability of the antigen matrices on the different plate types. 
 
3 Results and Discussion 
3.1 Cell-free expression of active HaloTag
®
 fusion antigens 
The overriding prerequisite for the given study is the success of Borrelia fusion 
antigen cell-free expression and interaction of the HaloTag
®–HaloLink™ system. 
Eleven antigens originating from different Borrelia species (Table 1) were expressed 
in an E. coli based cell-free expression system. By including the HaloTag
®
 sequence 
to the cDNA of the antigens, specific fusion protein detection with the HaloTag
® 
TMR-
ligand was possible. Previous experiments indicated that the HaloTag
® 
TMR-ligand 
only binds covalently to a soluble and active HaloTag
® 
fusion protein (data not shown). 
Therefore, activity of the HaloTag
®
 fusion protein is shown by the gels presented in 
supporting information Figure 1 since band detection was realized through 
fluorescence originating from the bound HaloLink™ TMR-ligand. Borrelia antigens, 
with exception of p100 B. burgdorferi sensu stricto, were successfully expressed in 
their soluble and active form with the E. coli cell-free expression system (supporting 
information Figure 1A) and purified by Ni-CS spin columns (supporting information 
Figure 1B). The HaloTag
®
 (32 kDa) was also expressed cell-free in relatively high 
amounts (red dotted line, supporting information Figure 1A). After the Ni-CS 
purification almost no tag contamination was visible (supporting information Figure 1B) 
in contrast to the nonpurified samples in supporting information Figure 1A. 
 
3.2 Development of microarray system based on cell-free expressed antigens 
Prior to a detailed comparison of microarrays based on cell-free and cell-based 
expressed antigens it was necessary to develop and optimize the cell-free expression 
and subsequent binding of the respective antigens. The CV values obtained with the 
72 Publications and Manuscripts 
14 patient sera were tested for the three antigen matrices and the two plate formats. 
When comparing CV frequencies as determined from the raw fluorescence data of 
spot replicates (Figure 2) a distinct performance could be observed. The CV values 
within the 15% range were for am-A, representing the cell-free expressed, unpurified 
antigens, 89% on the HaloLink™ and 97% on the MaxiSorp™ plate (Figure 2A). For 
both plate types am-B, the partially purified cell-free expressed antigens, showed for 
92% of all spot replicates a maximum CV of 15% (Figure 2B). This indicates high spot 
reproducibility for both antigen matrices on both plate types. 
 
  
 
 
Figure 2: Frequency distribution of coefficients of variation (CVs), ag detected with the 14 patient sera. 
(A) cell-free expressed, unpurified (am-A) and (B) cell-free expressed, purified Borrelia antigens (am-B) 
and (C) cell-based expressed and purified Borrelia antigens (am-C) on both plate types (MaxiSorp™ 
and HaloLink™). 
 
To ensure the comparability of the different antigen matrices and plate types of the 
cell-free expression system an ANOVA evaluation of the on-print controls was 
performed. It showed that both positive controls (IgG and IgM) and the HSA negative 
control generate a p-value higher than 0.05 (supporting informationTable 1) implying 
no significant difference between the three antigen matrices and the two plate types 
considering the controls. In contrast, the ANOVA of the E. coli lysate negative control 
showed a p-value less than 0.05 (supporting informationTable 1). Due to these 
significant differences of the lysate control am-A and am-B cannot be compared. 
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Therefore, a comparison to the cell-based system (am-C) was only performed for am-
B – the partially purified cell-free expressed antigens. 
For an evaluation of the suitability of the different plate types (HaloLink™ and 
MaxiSorp™) for the cell-free expressed am-B all antigens ag1 – ag11 were printed 
and incubated with patient serum eleven (ps11). The distinct microarray pattern of this 
analysis is shown in Figures 3A and B. The normalized fluorescence signals of the 
eleven Borrelia antigens developed with ps11 show high similarities. The mean 
scattering is slightly higher when using MaxiSorp™ plates. The print pictures of the 
seven spot replicates verify the fluorescence data. Similarly, when printing the cell-
based expressed and purified His-tagged antigens on both plate types, a statistical 
comparison with N-Way ANOVA shows that the null hypothesis is not rejected 
(p<0.05) implying no statistical significant difference between the two plate types.  
 
 
 
Figure 3: Boxplots of the normalized fluorescence data of the eleven Borrelia antigens (am-B - cell-free 
expressed HaloTag
®
 fusion proteins) printed on (A) HaloLink™ and (B) MaxiSorp™ plates, after 
detection with ps11. The corresponding seven replicates of the eleven Borrelia antigens as visible 
after microarray printing are illustrated below. (Numbering according to Table 1) 
 
3.3 Development of microarray system based on cell-based expressed antigens 
Analogous to the evaluation of comparability in the cell-free system the cell-based 
system – am-C – and plate format combinations were analyzed. After development 
with patient sera, spot reproducibility with regard to the different plate types was 
determined and the CV frequencies from the raw fluorescence data of the spot 
replicates (Figure 2C) were compared. 85% of the frequency distributions of all spot 
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replicates were found with a maximum CV of 15% on the HaloLink™ plates. For 
MaxiSorp™ an even higher value of 87% within the before mentioned CV range could 
be observed. This is an advantage, because all following comparisons of am-C are 
conducted on MaxiSorp™ plates. It indicates again high spot reproducibility for the 
am-C on both plate types. The frequency distributions of the CVs from the cell-free 
expressed, partially purified Borrelia antigens (Figure 2B; am-B) and the cell-based 
expressed Borrelia antigens (Figure 2C; am-C) on both plate types (MaxiSorp™ and 
HaloLink™) of all spot replicates with a maximum CV of 15% show an overall 
percentage of about 90. Therefore, the requirement of high spot reproducibility in all 
approaches and on both plate types is met. 
 
3.4 Microarray performance: Cell-free vs. cell-based expressed antigens 
In order to compare the feasibility of our approach and to evaluate the comparability of 
the microarrays produced with an antigen matrix based on cell-free synthesis and cell-
based expression we performed three interaction studies comprising mAb2 interaction 
with ag1 – ag11 (case 1), ps11 interaction with ag1 – ag11 (case 2) and ps1 – ps14 
interaction with ag6. We finally analyzed the complete matrix of interactions 
comprising ag1 – ag11, mab1 – mAb9 and ps1 – ps14 (case 4). All statistical 
comparisons between the plate type (HaloLink™ and MaxiSorp™), the application of 
monoclonal antibodies (mAb1 – mAb9) or patient sera (ps1 – ps14), and the eleven 
Borrelia antigens applied ag1 – ag11 (Table 1), were performed by N-Way ANOVA. 
3.4.1 Case 1: mAb2 interaction with ag1 – ag11  
For comparison of the two microarray approaches (am-B and am-C), boxplots for 
every monoclonal antibody or patient serum and the eleven Borrelia antigens of one 
plate type were generated. For arrays with am-B on HaloLink™ (Figure 4A) and am-C 
on MaxiSorp™ (Figure 4B) developed with mAb2, high similarities are apparent with 
specific detection of ag6 (DbpA, Borrelia afzelii). Equivalent results were found for 
three other proteins specifically detected by monoclonal antibodies, namely ag1 
(p100, B. burgdorferi sensu stricto) (protein was produced in an extra and further 
optimized cell-free expression), ag11 (OspA, B. afzelii) and ag8 (BmpA, B. afzelii) 
(data not shown). The mAbs detect the respective antigen specifically, showing almost 
no interaction with any other antigens. In addition, the detection intensities are very 
high, including very low standard deviations. The performance of the cell-free 
approach am-B is highly similar to the cell-based expressed antigens in am-C, 
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showing the applicability of the cell-free system for microarray screenings when mAbs 
are used. 
3.4.2 Case 2: ps11 interaction with ag1 – ag11 
Developing the arrays with patient sera generally led to a detection of more than only 
one antigen. By comparing the normalized fluorescence data of the eleven Borrelia 
antigens after development with ps11 in a boxplot and the corresponding microarray 
printing profiles in Figure 4C and D, the proteins ag2 (VlsE1, B. garinii), ag6 (DbpA, 
B. afzelii) and ag9 (OspC, B. spielmanii) display the highest normalized fluorescence 
values indicating specific detection in both approaches (Figs. 4C and D). No 
significant difference between the matrix am-B (Figure 4C; HaloLink™) and am-C 
(Figure 4D; MaxiSorp™) as well as the respective plate type is observable. The 
variation between the seven print replicates is slightly lower when comparing the cell-
free expressed antigens on the HaloLink™ plate to am-C. However, the MaxiSorp™ 
plate already showed a slightly higher mean scattering before in the plate comparison 
experiments when only am-B was printed. The specific detection of both systems is 
comparable and therefore, the applicability of am-B in contrast to am-C could be 
shown for ps11. 
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Figure 4: Boxplots of the normalized fluorescence data of the eleven Borrelia antigens after detection 
with mAb2 (A and B) and ps11 (C and D). The corresponding seven replicates of the eleven Borrelia 
antigens as visible after microarray printing are illustrated below. (A and C) am-B (cell-free expressed 
Borrelia HaloTag
®
 fusion proteins purified by Ni-CS) on HaloLink™ plates. (B and D) am-C (cell-based 
expressed Borrelia antigens IMAC-purified) on MaxiSorp™ plates. (Numbering according to Table) 
 
3.4.3 Case 3: ps1 – ps14 interaction with ag6 
In addition to the comparison of the two microarray plates (HaloLink™ and 
MaxiSorp™) after development by one certain patient serum, Figure 5 illustrates 
fluorescence data of ag6 (DbpA from B. afzelii) after incubation with the 14 patient 
sera and the negative control (blood donor serum). The bar plots depict the 
normalized fluorescence data with the different patient sera on the microarray matrix 
am-B on HaloLink™ (Figure 5A) and am-C on MaxiSorp plates ™ (Figure 5B). The 
latter two microarray types show high similarities for the 14 patient sera and the blood 
donor. The data indicates that ag6 (DbpA, B. afzelii) detection with seven of the 
patient sera was just as small as with the negative control serum. In all these cases 
the normalized fluorescence data are close to zero (Figure 5). However, seven patient 
sera react positively with ag6 (DbpA, B. afzelii) in both approaches, a finding that is 
reproducible for the seven spots respectively (Figs. 5A and B). Overall, eight out of 
eleven Borrelia antigens reacted similarly on the different plate types in both 
approaches. Since the interactions of the cell-free expressed antigens are similar to 
the cell-based expressed antigens over the patient sera used in this study, specific 
detection is possible with cell-free expressed antigens and the applicability of this 
system could be shown. 
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Figure 5: Bar plots of the normalized fluorescence data of ag6 DbpA from B. afzelii after detection with 
the 14 different patient sera (N = blood donor serum). The error bars represent the standard deviation. 
The corresponding seven replicates of DbpA from B. afzelii after the particular developments as 
visible after microarray printing are illustrated below. (A) am-B (cell-free expressed Borrelia HaloTag
®
 
fusion proteins purified by Ni-CS) on HaloLink™ plates. (B) am-C (cell-based expressed Borrelia 
antigens IMAC-purified) on MaxiSorp™ plates. 
 
3.4.4 Case 4: Overall data evaluation – ag1-ag11 / mAb1-mAb9 / ps1-ps14  
By comparing the antigen matrices B and C on both plate types, four out of eleven 
Borrelia antigens were statistically different from the others to positive detection by the 
monoclonal antibodies (Figure 6A). For the other seven Borrelia antigens it was not 
possible to reject the null hypothesis and therefore no significant effect can be 
assumed when compared to the negative on-print control (HSA). Likewise for three 
out of the eleven Borrelia antigens the null hypothesis could not be rejected after 
incubation with the 14 patient sera and hence could not be detected with the sera pool 
of this study (Figure 6B). However, ag11 (OspA, B. afzelii) was detectable by mAb6. 
Only two of the eleven antigens – ag3 and ag7 - remained undetermined after 
measurement. Therefore, 82% of the Borrelia antigens examined were detected by 
the different patient sera and monoclonal antibodies applied, illustrating the suitability 
of the investigated antigens. From the results obtained it is evident that printing cell-
free expressed Borrelia antigens is reproducible, even on different plate types. With 
the on-print controls the comparability between the different approaches (e.g. cell-
based and cell-free expressed proteins, usage of different plate types etc.) is indicated 
and viable. In addition, the results obtained in the different approaches, including 
different microarray plate surfaces and antigen matrices, show – based on statistical 
evaluations – a high similarity. The results are thus a successful demonstration of the 
feasibility to apply a time- and resource-saving combination using cell-free expressed 
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proteins for printing, successfully to a recombinant antigen system for the diagnosis of 
Lyme borreliosis. HaloTag
®
 fusion proteins are to date pipetted in gaskets onto the 
HaloLink™ surfaces, which differs from the printing process basically in reagent 
volume and sample number [151]. In this study we printed the cell-free expressed 
HaloTag
®
 fusion proteins, increasing the number of possible experiments from 50 per 
slide in conventional methods up to a spot density of 196 dots per well of a microtiter 
plate.  
 
  
Figure 6: Multcompare plots illustrating the eleven Borrelia antigens as well as the negative control (N 
= HSA) after detection with the nine mAbs (A) and the 14 patient sera (B) as calculated by N-Way 
ANOVA. (Numbering according to Table 1) 
 
4 Concluding remarks 
Previously, proteins for microarray applications were expressed in cell-based systems, 
which is time and material-consuming. New applications using cell-free expression for 
a cheap and fast alternative printed the DNA molecules, but not the proteins itself. 
Therefore, the comparability to protein microarrays is challenging. This study provides 
a proof of principle for the identification of potential new biomarkers using proteins 
from cell-free expression combined with multiplex protein microarrays, representing a 
fast and cost-reducing approach compared to cell-based expression and conventional 
analytic methods. Furthermore, the comparability to cell-based expressed protein 
microarrays could be reproducibly shown and hence the improvement of printing 
conditions is now possible. Future applications may expand the diagnostic potential to 
simultaneous analyses of an almost arbitrarily high number of e.g. biomarkers in a 
relatively short time.  
  
Publications and Manuscripts 79 
Acknowledgements 
We gratefully acknowledge the financial support by the Federal Ministry of Education 
and Research (BMBF) on the grant number 0315334A. The authors have declared no 
conflict of interest. 
 
80 
 
4 Conclusion and Outlook 
The research outcome of this study contributes to help simplifying and accelerating 
the biochemical protein production and analysis. Recently, a high number of genes 
from different species were identified. However, conventional cell-based expression is 
limited in expressing these gene sequences for functional classification and validation 
of the corresponding proteins. To overcome these limitations, cell-free expression can 
be used to produce these proteins which are of high value in the personalized 
medicine and pharmaceutical research.  
Through the application of DoE and model-based analysis the influences of the 
different premix components and their concentrations on the luciferase expression 
yield of two different insect cell extracts (Sf9 and High Five™) were observed and 
characterized. The use of the high-throughput method enables many data points to be 
generated. To the experimental data quadratic response surface models were fitted 
and model predictivity was validated successfully. The characterization of the 
complete in vitro translation process included quantification and visualization of the 
parameter influences on the expression yield and the robustness of the systems. 
Furthermore, the results extend and simplify previous insect cell-free optimizations. 
Therefore, the establishment of a new method for further investigations and 
optimization experiments of cell-free extracts in different cell types has been 
successfully accomplished. In the future, using this comprehensive system 
characterization based on optimally designed high-throughput screenings on robotic 
systems a further enhancement of protein yield as well as cell-free system 
optimizations regarding single protein expression improvements can be established.  
Furthermore, this thesis showed that cell-based protein expression optimization using 
cell-free expression systems is possible. The process parameters established during 
the cell-free approach could be successfully transferred to the cell-based system. 
Additionally, this research showed the importance of protein folding for the 
overexpression of heterologous proteins in E. coli. For the first time, a soluble, full-
length and immunologically active U1-68/70 K autoantigen was expressed in E. coli 
cells. Further understanding of the human U1-68/70 K full-length protein and the 
spliceosomal complex including U1-68/70 K and its role in autoimmunity is now 
possible.  
We established a procedure for the cell-free expression and subsequent printing of 
different Borrelia antigens onto several multi-well microarray plate surfaces. This is a 
fast and cost-saving approach compared to cell-based expression and conventional 
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analysis methods. Furthermore, the statistical analysis showed that cell-free 
expression is reproducibly comparable to cell-based expressed protein microarrays. 
Furthermore, the improvement of printing conditions, depending on expression 
techniques, is now possible. Therefore, this approach serves as a proof of principle for 
the identification of potential biomarkers. In the future, it offers the possibility of 
multiplex protein detection for specific diseases and may therefore expand the 
diagnostic biomarker portfolio in a relatively short time.  
Overall the research in this thesis shows different types of applications of cell-free 
expression. Despite the recently significantly improved reaction yields in in vitro 
protein production systems the potential for optimization is not yet exhausted. 
Especially linking cell-free expression to protein analysis needs further examination. In 
the future, cell-free expressions with integrated folding proteins or other additives will 
expand the portfolio of desired protein for personalized medicine and pharmaceutical 
research. 
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5 Abbreviations 
adenosine triphosphate (ATP) 
amino Acids (AA) 
analysis of variance (ANOVA) 
antigen (ag) 
antigen matrix (am) 
base pair (bp) 
calcium chloride (CaCl2) 
coefficient of variation (CV) 
complementary DNA (cDNA) 
coenzym A (CoA) 
creatine kinase (CK) 
creatine phosphate (CP)  
cytosin triphosphate (CTP) 
deoxyribonucleic acid (DNA) 
design of experiments (DoE) 
Dithiothreitol (DTT) 
ethylene glycol tetraacetic acid (EGTA) 
enzyme-linked immunosorbent assay (ELISA) 
Escherichia coli (E. coli) 
green fluorescent protein (GFP) 
guanosine triphosphate (GTP) 
hexahistidine (His) 
high-throughput (HT) 
high-throughput screening (HTS) 
human serum albumin (HSA) 
immunglobulin G (IgG) 
immunglobulin M (IgM) 
kilo base pair (kbp) 
magnesium acetate (MgO(Ac)2) 
mass spectrometry (MS) 
matrix-assisted laser desorption/ionization (MALDI) 
messenger ribonucleic acid (mRNA) 
mixed connective tissue disease (MCTD) 
monoclonal Antibody (mAb) 
multivariate data analysis (MVDA) 
Nickel Chelating Sepharose Fast Flow (Ni-CS) 
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nicotinamide adenine dinucleotide (NAD) 
probability value (p-value) 
patient sera (ps) 
polymerase chain reaction (PCR) 
potassium acetate (KOAc) 
prediction sum of squares (PRESS) 
ribonucleic acid (RNA) 
root mean square error (RMSE) 
small nuclear ribonucleic particles (snRNP) 
sodium chloride (NaCl) 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
spot replicate (r) 
tandem mass spectrometry (MS/MS) 
transfer ribonucleic acid (tRNA) 
uracil triphosphate (UTP) 
untranslated region (UTR) 
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                    (His-tag) 
                     -8        1       10         20         30         40 
U1-68/70 K           (MHHHHHHA) MTQFLPPNLL ALFAPRDPIP YLPPLEKLPH EKHHNQPYCG 
U1-68/70 K_truncated (MHHHHHHA) MTQFLPPNLL ALFAPRDPIP YLPPLEKLPH EKHHNQPYCG 
                               ********** ********** ********** ********** 
                            50         60          70         80        90 
U1-68/70 K           IAPYIREFED PRDAPPPTRA ETREERMERK RREKIERRQQ EVETELKMWD 
U1-68/70 K_truncated IAPYIREFED PRDAPPPTRA ETREERMERK RREKIERRQQ EVETELKMWD 
                    ********** ********** ********** ********** ********** 
                           100        110        120        130        140 
U1-68/70 K           PHNDPNAQGD AFKTLFVARV NYDTTESKLR REFEVYGPIK RIHMVYSKRS 
U1-68/70 K_truncated PHNDPNAQGD AFKTLFVARV NYDTTESKLR REFEVYGPIK RIHMVYSKRS 
                    ********** ********** ********** ********** ********** 
                           150        160        170        180        190 
U1-68/70 K           GKPRGYAFIE YEHERDMHSA YKHADGKKID GRRVLVDVER GRTVKGWRPR 
U1-68/70 K_truncated GKPRGYAFIE YEHERDMHSA YKHADGKKID GRRVLVDVER GRTVKGWRPR 
                    ********** ********** ********** ********** ********** 
                           200        210        220        230        240 
U1-68/70 K           RLGGGLGGTR RGGADVNIRH SGRDDTSRYD ERDRDRDRER ERRERSRERD 
U1-68/70 K_truncated RLGGGLGGTR RGGADVNIRH SGRDDTSRYD ERDRDRDRER ERRERSRERD 
                    ****************************************************** 
     Inhibitory sequence X [16]  
                           250        260        270        280        290 
U1-68/70 K           KERERRRSRS RDRRRRSRSR DKEERRRSRE RSKDKDRDRK RRSSRSRERA 
U1-68/70 K_truncated KERERRRSRS RDRRRRSRSR ---------- ---------- ---------- 
                    ********** **********                                  
                           300        310        320        330        340 
U1-68/70 K           RRERERKEEL RGGGGDMAEP SEAGDAPPDD GPPGELGPDG PDGPEEKGRD 
U1-68/70 K_truncated ---------- ---------- ---------- ----- GPDG PDGPEEKGRD 
                                                           **** ********** 
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                           350        360        370        380        390 
U1-68/70 K           RDRERRRSHR SERERRRDRD RDRDRDREHK RGERGSERGR DEARGGGGGQ 
U1-68/70 K_truncated RDRERRRSHR SERERRRDRD RDRDRDREHK RGERGSERGR DEARGGGGGQ 
                    ********** ********** ********** ********** ********** 
                                                             His-tag 
                           400        410        420      428        
U1-68/70 K           DNGLEGLGND SRDMYMESEG GDGYLAPENG YLIEAAPEHH HHHH 
U1-68/70 K_truncated DNGLEGLGND SRDMYMESEG GDGYLAPENG YLMEAAPEHH HHHH 
                    ********** ********** ********** ********** **** 
Figure A.1: Comparison of the amino acid sequences of C-terminally His-tagged full-length and 
truncated U1-68/70 K. 
 
Table 1: MS-determined peptide masses of the U1-68/70 K full-length protein. The four main fragments 
marked with (*) were confirmed by MS/MS analysis. 
Mass Position Peptide sequence 
3373.3920 302-335 GGGGDMAEPSEAGDAPPDDGPPGE
LGPDGPDGPEEK* 
1842.7864 88-103 MWDPHNDPNAQGDAFK* 
1659.7917 385-402 GGGGGQDNGLEGLGNDSR* 
1413.6433 145-155 GYAFIEYEHER* 
1281.7089 17-27 DPIPYLPPLEK 
1103.5579 79-87 QEVETELK 
1081.5564 122-130 EFEVYGPIK 
1056.4844 110-118 VNYDTTESK 
829.4778 174-180 VLVDVER 
 
Figure A.2: Peptide mass fingerprint of U1-68/70 K full-length protein. 
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Table 1: ANOVA p-values of on-print controls. 
on-print control p-value 
Human serum albumin 0.29 
Escherichia coli lysate 0.00 
IgG 0.37 
IgM 0.92 
 
 
Figure 1: SDS-Page analysis of eleven in vitro expressed Borrelia HaloTag
®
 fusion antigens (A) 
unpurified and (B) Ni-CS purified; detected with the HaloTag
®
 TMR ligand, measured in a fluorescence 
scanner using the Cy2 channel. HT: HaloTag
®
 protein, N: negative control (E. coli lysate). The 
HaloTag
®
 (32 kDa) was expressed in relatively high amounts (red dotted line). (Numbering according 
to Table 1 in the research article) 
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